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 Chapter 1 
 
 
 
General introduction 
 
  
 GENERAL INTRODUCTION. 
 
Spinal pain is a major public health problem. The Global Burden of Disease Study 
from 2010 showed that globally, low back pain is the most prevalent musculoskeletal 
disorder causing disability and neck pain is the fourth most prevalent, out of 289 
diseases and injuries.1 A Dutch study in 2003 showed a self-reported point 
prevalence for low back pain of 27% and for neck pain of 21%.2 The Dutch institute 
for health service research (NIVEL) found that in 2015 neck pain is the most 
prevalent disorder (10.2%) and low back pain the second (8.1%) disorder in Dutch 
physical therapy practice.3 The NIVEL also found that in 2016 the prevalence of (non 
radiating) low back pain in Dutch general practitioners practice was 30.4 per 1000 
patient years and for neck pain this was 20.8 per 1000 patient years.4 
Both low back pain and neck pain are associated with financial burdens to society. In 
the Netherlands the costs for low back pain decreased from 4.2 billion euro in 1991 
to 3.5 billion in 2002. This decrease is mainly attributed to lower indirect costs due to 
a change of policy in regards to sickness benefits and reintegration in the 
Netherlands. 5 The 2002 low back pain costs consisted of 385 to 455 million euro’s in 
direct medical costs and between 3 and 3.1 billion euro’s in indirect costs.5 In 1996 
the annual cost of neck pain in The Netherlands was estimated to be 668 million US 
dollars.6 A study performed in the United States compared healthcare costs of 
patients with and without spinal pain in 1997 and than compared these with data 
from 2005. Spinal related problems were responsible for 9% health care costs in the 
United States. Results from this study showed a faster increase of heath costs in 
patients with spinal pain.7 It may be assumed that the Dutch healthcare costs are 
likely to have been increased since 1996. 
 
Low back pain 
Low back pain is often classified as being either specific or non-specific. Specific low 
back pain refers to a specific objectively assessed condition or underlying pathology 
such as: tumors, fractures and infections. Nerve root compression as a result of a 
stenosis or herniated disc is often considered as a non-serious specific low back 
pain condition instead of a non-specific condition although the relation between 
herniated discs and low back pain is unclear.8,9 This is enforced by studies showing 
a large proportion (36%) of people without back pain having signs of a herniated disk 
on a MRI.10 The majority, over 85%, of patients with low back pain the condition is 
regarded non-specific, meaning there is no known underlying disease or 
pathology.11–13 
Non-specific low back pain is regarded as being a self -limiting condition. Recovery 
usually occurs within a few weeks after the onset of pain.14,15 Recent prognostic 
studies however showed that around 40% of patients with low back pain will take 
longer than 12 weeks to recover.13,16,17  
 
 Guidelines 
The Royal Dutch Society for Physical Therapy (KNGF) guideline for low back pain 
categorises patients based on the course of recovery, that is patients are considered 
to have either a normal or a deviant course of recovery. Deviant course of recovery 
is defined when over a period of three weeks there is no increase in activities or 
participation.14 The course of recovery of the low back pain determines the 
treatment. In case of a normal recovery there seems to be no reason to provide 
physiotherapy treatments as the pain is likely to resolve.14 When recovery is 
regarded deviant, factors responsible for this deviant course are identified and they 
can be either psychosocial or non-psychosocial. The American Physical Therapy 
Association (APTA) also recommends a classification system in their clinical 
guideline on low back pain but this classification system differs from the one 
proposed in the KNGF guideline. The APTA classification is based on the 
International Classification of Functioning, Disability, and Health (ICF). These 
include; a) acute or sub-acute low back pain with mobility deficits; b) acute, sub-
acute, or chronic low back pain with movement coordination impairments; c) acute 
low back pain with related (referred) lower extremity pain; d) acute, sub-acute, or 
chronic low back pain with radiating pain; e) acute or sub-acute low back pain with 
related cognitive or affective tendencies, and f) chronic low back pain with related 
generalized pain. 
The Dutch general practitioners guideline, as well as other international guidelines, 
includes three management components: (a) reassurance of patients that there is no 
serious cause for their back problem and the pain is likely to resolve rapidly, (b) 
simple analgesia to help control symptoms and (c) advice patients to stay active and 
avoid bed rest.18–20 Unfortunately there is evidence that large proportions of general 
practitioners and physical therapist do not adhere to clinical practice guidelines.21–23 
When general practitioners do adhere to the guideline and the previous mentioned 
advise is given we hope patients to adhere to this advice because not adherence 
could delay recovery and/or lead to higher health related costs. Knowledge on 
patients’ non-adherence is often limited to medication. Therefore we need more 
insight in the non-adherence to the advice and insight in aspects related to the non-
adherence. For example; can we predict which patients are likely to not adhere? This 
knowledge may help clinicians to improve these patients’ compliance. 
 
Prediction models 
Several tools are available to screen, or predict persisting low back pain. The most 
common is the Keele STarT Back Tool (Subgroups for Targeted Treatment) (SBT).24 
In 2008 the SBT was developed in the United Kingdom as a brief and user-friendly 
tool. A questionnaire consisting of nine item using treatment modifiable factors, such 
as function, psychosocial and comorbid factors for subgrouping. This tool aims not 
only to subgroup patients as low risk, medium risk, or high risk for persisting low 
back pain. The primary aim of the tool is to provide a targeted treatment for each 
 subgroup. The advised targeted treatment for the SBT is for all patients to receive 
information and advice; in addition, both “medium-” and “high-risk” patients receive 
standardized physiotherapy to address symptoms and function, and “high-risk” 
patients also receive psychologically informed physiotherapy to address the 
psychosocial obstacles to recovery.25 The SBT approach shows great similarities 
with the general practitioners’ guideline with the difference that the general 
practitioners approach is a stepped care meaning that every step is taken in a timely 
fashion: the first step is that reassurance and/or advise is given, when this is 
insufficient the next step is taken; the patient is referred to a physiotherapist and so 
on. The SBT approach is a stratified care meaning that at the first consultation the 
appropriate therapy is determined. 
The SBT has been translated in 2011 into Dutch and some practitioners in Dutch 
primary care have implemented it. No studies are done on the reliability and validity 
of the Dutch SBT. It is unknown if the tool can predict persisting disability in the 
Netherlands and if the tool is able to stratify patients between low, medium, and high 
risk. Due to the similarities between the SBT and the available guidelines it can be 
argued if we need a tool like the SBT. Maybe Dutch clinicians can provide the correct 
stratified care based on their own clinical experience or gut feeling.  
 
Neck pain 
Globally, neck pain is the fourth largest musculoskeletal disorder causing disability.1 
The estimated one-year incidence of neck pain varies between 10.4 to 21.3%.26 In 
patients with acute neck pain, pain and disability decrease in the first six weeks with 
approximately 45%, but little or no decrease in pain and function limitations can be 
found afterwards.27 A Dutch cohort study found that after one year 76% of patients 
reported to be fully recovered or much improved, indicating that still in many patients 
the complaints persist over time and or are recurrent.28  
Neck pain is described as ‘an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage’ in the neck region.29 The Neck 
Pain Task Force (NPTF) divides neck pain into four grades.30,31 
 
  
 Grade I Neck pain and associated disorders with no signs or symptoms 
suggestive of major structural pathology and no or minor interference with 
activities of daily living 
Grade II No signs or symptoms of major structural pathology, but major 
interference with activities of daily living 
Grade III No signs or symptoms of major structural pathology, but presence of 
neurologic signs such as decreased deep tendon reflexes, weakness, or 
sensory deficits 
Grade IV Signs or symptoms of major structural pathology. Major structural 
pathologies include (but are not limited to) fracture, vertebral dislocation, 
injury to the spinal cord, infection, neoplasm, or systemic disease 
including the inflammatory arthropathies.  
 
Grades I thru III can be divided include two specific subgroups of patients with neck 
pain: trauma-related neck pain (previously known as whiplash or whiplash 
associated disorder (WAD) and work-related neck pain, based on patient’ statement 
on the cause or onset of pain.32,33 
 
Guidelines 
Dutch general practitioners and Dutch physical therapists do not have a clinical 
practice guideline on neck pain. Other general practitioner and physical therapy 
guidelines are available but only cover a subgroup of the neck pain population, such 
as WAD or CANS (Complaints on Arm Neck or Shoulder).34–36 International 
guidelines are available that cover neck pain including WAD.37,38 These guidelines 
use the grading systems as proposed by the Neck Pain Task Force to classify 
patients.37 Alternatively the classification is made by means of International 
Classification of Functioning, Disability, and Health (ICF). These classify patients into 
one of the following impairments: Neck pain with mobility deficits, neck pain with 
headaches, neck pain with movement coordination impairments, or neck pain with 
radiating pain.38  
In the bone and joint decade from 2000 to 2010 the United Nations and World Health 
Organization initiated “The task force on neck pain and its associated disorders”. In 
that period members from the task force produced a best evidence synthesis from 
552 scientific papers.39 With this evidence available and the high prevalence of neck 
pain in the Dutch primary care it is due time for a clinical practice guideline on neck 
pain. 
 
Prediction models 
Models such as the SBT often focus on low back pain and to a lesser extend on neck 
pain. The SBT has been modified in the United Kingdom (UK) to fit patients with 
other musculoskeletal conditions including neck, upper limb, lower limb or multisite 
pain to become the SBT-MSK (musculoskeletal).40,41 A study in the UK on the SBT-
 MSK found that is was not yet ready for clinical implementation.41 The authors of the 
SBT also developed an alternative to the SBT to fit other musculoskeletal conditions 
such as the neck pain. The Arthritis Research UK Musculoskeletal Health 
Questionnaire (MSK-HQ) has been developed in four cohorts it was found to have 
good completion rates, test–retest reliability and convergent validity with reference 
standards.42 Further validation studies are necessary to determine the predictive 
validity for persisting disability and the applicability in patients with neck pain. These 
screening tools are all developed in the UK and validated in their health care system. 
As there are large differences between the healthcare systems in the UK and the 
Netherlands, cultural differences, and of course the language difference the 
screening tools need to be translated and validated in the Netherlands before we can 
determine if it can be used in the Dutch population. 
 
Scope and aim of the study 
The common goal of the studies in this thesis is to provide insight in prognosis and 
optimal care for patients with spinal pain in primary care (general practitioners and 
physical therapists). We aim to: 
• Describe non-adherence to guideline-recommended care of patients with 
acute LBP and to explore factors associated with non-adherence. (Chapter 2) 
• Translate, and investigate the reliability and validity of the SBT in the Dutch 
primary care setting among patients with non-specific low back pain. (Chapter 
3) 
• Modify and evaluate the reliability and validity of the Dutch Version of the SBT 
for patients with neck pain. (Chapter 4) 
• Evaluate whether current Dutch primary-care clinicians offer tailored treatment 
to patients with lower-back pain or neck pain according to their risk 
stratification, based on the SBT. (Chapter 5) 
• Provide a clinical practice guideline for physical therapists for the assessment 
and management of patients with neck pain in Dutch primary care. (Chapter 
6) 
 
In Chapter 2 we describe the results of a secondary analysis of the PACE-trial and 
concerns data of 1642 patients in 235 primary care centres in Sydney, Australia, 
gathered between November 11, 2009 and March 5, 2013. The PACE-trial studied 
the efficacy of paracetamol taken regularly or as-needed compared with placebo to 
improve time to recovery from acute low back pain. Patients were randomised in one 
of three groups and Australian general practitioners provided guideline-
recommended care. This care consists of advise against bed rest, continue normal 
daily activities, advise against other treatments and tests and the use of study-
medication. This could be paracatamol in a time-contingent dosing, or an as-required 
dosing, or placebo. We analysed and described the magnitude of patient reported 
 non-adherence with guideline-recommended care for acute low back pain, and to 
explore possible factors associated with non-adherence. 
Chapter 3 though 5 report on the PRINS study; Prevalence of RIsk groups in Neck- 
and back pain patients according to the STarT back screening tool. This is a 
prospective cohort study including 284 patients whose primary complaint was low 
back pain or neck pain that consulted the physiotherapist or general practitioner. A 
questionnaire was sent to the patient at baseline and at follow-up at three days and 
three months. The construct validity, content validity, reproducibility, and predictive 
validity for persisting complaints were assed. The clinicians were blinded for the 
results of the questionnaire and provided usual care. Chapter 3 investigates whether 
the Dutch version of the SBT for low back pain has the ability to predict persisting 
low back pain in primary care patients in the Netherlands. For this we analysed 184 
patients with low back pain. In Chapter 4 we describe the changes we made to the 
SBT to fit patients with neck pain. We report about the ability of the SBT-neck to 
predict persisting neck pain. For this we analysed 100 patients with neck pain. In 
Chapter 5 we report on the data we collected on the clinicians’ usual care. We 
determined at baseline whether the patient was low, medium or high risk for 
persisting low back or neck pain according to the SBT. We analysed the clinicians’ 
data concerning the management of these patients and determined whether the 
clinicians provided corresponding targeted treatments according to the SBT to these 
patients. We describe the usual care for patients with neck pain or low back pain 
separately. 
In Chapter 6 we describe the current available evidence for diagnosing, and treating 
patients with neck pain as reported in the clinical practice guideline on adult patients 
with neck pain treated by physiotherapists in the Netherlands. The guideline focuses 
on non-specific neck pain and cervical radiculopathy. Interventions include: cognitive 
behavioral treatment, cervical collar, dry needling, education, electrotherapy, 
exercise, joint mobilization, kinesiotape, low level laser therapy, manipulation, 
massage, neurodynamics, pillow, thermal agents, traction, shockwave, and 
workplace interventions. 
In Chapter 7 the main findings of this thesis are summarized and discussed and 
recommendations for research and clinical practice are presented. 
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 ABSTRACT 
 
Objective: 
To describe the magnitude of patient-reported nonadherence with guideline-
recommended care for acute low back pain. 
 
Design: 
Secondary analysis of data from participants enrolled in the PACE trial, a 
randomized controlled trial evaluating the effectiveness of paracetamol for acute low 
back pain. 
 
Setting: 
Primary care, General practitioner 
 
Participants: 
Data from participants with acute low back pain (N=1643). 
 
Interventions: 
Guideline-recommended care, including reassurance, simple analgesia, and the 
advice to stay active and avoid bed rest. Also, advice against additional treatments 
and referral for imaging. 
 
Main Outcome Measures: 
Proportion of nonadherence with guideline-recommended care. Nonadherence was 
defined as (1) failure to consume the advised paracetamol dose, or (2) receipt of 
additional health care, tests, or medication during the trial treatment period (4wk). 
Multivariable logistic regression analysis was performed to determine the factors 
associated with nonadherence. 
 
Results: 
In the first week of treatment, 39.7% of participants were classified as nonadherent. 
Over the 4-week treatment period, 70.0% were nonadherent, and 57.5% did not 
complete the advised paracetamol regime. Higher perceived risk of persistent pain, 
lower level of disability, and not claiming workers’ compensation were associated 
with nonadherence, with odds ratios ranging from .46 to 1.05. 
 
Conclusions: 
Adherence to guideline-recommended care for acute low back pain was poor. Most 
participants do not complete the advised paracetamol regime. Higher perceived risk 
of persistence of complaints, lower baseline disability, and participants not claiming 
workers’ compensation were independently associated with nonadherence.   
 BACKGROUND 
 
Globally, low back pain (LBP) causes more disability than any other condition.1 In the 
United States estimated costs attributable to LBP range from $86 billion to $238 
billion per year.2–4 It is mostly managed in primary care with 12% to 32% of patients 
with LBP consulting a general practitioner (GP).5–7 International clinical practice 
guidelines recommend a similar management approach for the first-line care of 
patients with acute nonspecific LBP: (1) reassurance that there is no serious cause 
for their back problem and the pain is likely to resolve rapidly, (2) simple analgesia 
(eg, paracetamol) to help control symptoms, and (3) advice to stay active and avoid 
bed rest.8,9 There is evidence that providing additional treatments to first-line care 
does not provide additional benefit.10–12 Guidelines recommend that additional 
treatments should be reserved for patients who do not recover. Referral for imaging 
(eg, radiographs, computed tomography scans, magnetic resonance imaging) is 
discouraged because it offers no diagnostic benefit, nor does it improve clinical 
outcomes; in fact, it may be associated with poorer outcomes (eg, lower quality of 
life).8,13 
There is an extensive body of literature focusing on adherence to guideline-
recommended care because this has been shown to result in better outcomes for 
patients.14–18. Much of this evidence focuses on clinician prescribing behaviour and 
provision of care. However, little has been published on the extent to which patients 
adhere to guideline-recommended care when it is provided. Research to date has 
identified some factors associated with nonadherence to medication, including; age, 
gender, baseline disability, perceived health, fear of side effects, limited English 
proficiency, lack of a social support, and forgetfulness.19–23 The few studies on 
chronic pain suggest nonadherence to recommended medication can lead to 
worsening of symptoms, higher disability and higher utilisation of healthcare.20,24 
Although providing guideline-recommended care to patients does lead to improved 
outcomes and concurrent lower costs of care for LBP, delivering this care is 
redundant if patients do not adhere to recommendations.  
Understanding the aspects of care that patients do not adhere to, and the 
characteristics of nonadherent patients, can help in design of targeted strategies to 
address suboptimal adherence. The primary aim of this study was to describe the 
degree of nonadherence to guideline-recommended care of patients with acute LBP, 
in terms of early nonadherence (during the first week of treatment), and over the 4-
week treatment period. A secondary aim was to explore possible factors within the 
available data set, associated with non-adherence. 
 
 
 
 
 
 METHOD 
 
Data source 
This is a secondary analysis of the PACE study; a randomised placebo-controlled 
trial which aimed to assess the efficacy of paracetamol in patients with acute LBP.9 
The PACE study included 1643 patients who attended a primary care clinic (Sydney, 
NSW, Australia) for acute LBP. Detailed description of the trial methods and analysis 
plan are published elsewhere.25,26 The PACE study found no differences in recovery 
time or pain intensity between the paracetamol and placebo group.9 
 
Study Procedure 
All participants received information from a trained clinician about the favourable 
prognosis of their LBP, the low likelihood of a serious disease, and reassurance that 
complete recovery is highly likely. They were advised against bed rest and to 
continue their normal daily activities, and informed that the study medication would 
assist this. Study personnel reinforced these messages over the telephone at 
baseline assessment. Participants and clinicians were asked not to undertake other 
treatments and tests because these were unlikely to provide any benefit at this 
stage.  
The trial used a double dummy design to compare the effects of time-contingent 
dosing of paracetamol, as-required dosing of paracetamol, and placebo25,27 (table I).  
 
Table I; Medication schedule for all treatment arms  
    Group    Pack  Schedule Time-contingent PRN Placebo 
    Paracetamol Paracetamol   
Regular Morning 2 active tablets 2 placebo tablets 2 placebo tablets 
  Noon 2 active tablets 2 placebo tablets 2 placebo tablets 
  Night 2 active tablets 2 placebo tablets 2 placebo tablets 
As required 1-2 placebo tablets  1-2 active tablets 1-2 placebo tablets  
    max 8 per 24 hours max 8 per 24 hours max 8 per 24 hours 
 
Data collection 
Participants completed questionnaires at baseline, and at weeks 1, 2, 4 and 12. A 
medication diary was used to record daily pain (on a 0-10 numerical pain rating 
scale) and the number of each type of study tablet taken. 
Baseline characteristics included days since onset of pain, perceived risk of 
persistent pain, presence of pain beyond the knee, number of days of reduced 
activity, disability (Roland Morris Disability Questionnaire; range, 0-24), worker’s 
compensation, health insurance status, income level, treatment credibility (range 3-
27) and expectation score (range, 3-27) both taken from credibility expectancy 
 questionnaire, feelings of depression in the past week (range, 0-10)28, number of 
previous episodes and good sleep quality 
Follow-up items at week 1 and 2 included: pain intensity, recovery, sleep quality, 
disability, patient specific complaints, additional treatments and GP visits and 
adverse events. At week 4 additional items included a patient reported inventory of 
all treatments utilised (health services, medications and community services) over 
the past 4 weeks, quality of life, the number of hours of reduced work time (each 
week for previous 4 weeks). 
After week 4, participants were asked to return unused study medication packages 
and to complete a self-reported medication adherence rating scale (Brief Adherence 
Rating Scale). 
 
Outcome measurement 
The primary outcome for the current study was ‘overall nonadherence’ to guideline-
recommended care. We considered ‘overall nonadherence’ at 2 time points: (1) early 
nonadherence, defined as nonadherence to the study medication or the use of 
additional treatments (ie, other than the study treatments) in the first week; and (2) 4-
week nonadherence defined as nonadherence to study medication, or the use of 
additional treatments (ie, use of other medication or health services) over the 4 
weeks of the study treatment period. 
We also described the individual aspects of nonadherence separately for each time 
point: for early nonadherence, nonadherence to (1) the study medication and (2) the 
use of additional treatments; for 4 week nonadherence, nonadherence to (1) study 
medication, (2) use of other medications, and (3) use of other health services. 
The criterion for nonadherence to study medication in the first week was defined as 
taking <70% of the recommended regime of the regular study medication in the first 
week. The criterion for 4-week nonadherence to study medication was taking <70% 
of the recommended regime for <70% of the recommended treatment days (ie, until 
recovery or the end of 4wk). 
 
Statistical analysis 
We calculated descriptive statistics for baseline characteristics and non-adherence. 
Because worsening of symptoms could initiate additional medication or referral for 
other treatment,8 we also calculated nonadherence, which was adjusted for 
worsening of symptoms. In this analysis, participants who had worsening symptoms 
and used additional treatments, tests, or medications were considered adherent. 
Worsening of symptoms was defined as an increase in pain ≥2 points and 
deterioration on the Global Perceived Effect scale (score, -2 to -5).29,30  
We performed a multivariate logistic regression analyses to determine the 
associations between the baseline characteristics (independent variables) and 4 
dependent variables: the 4-week (1) overall nonadherence, (2) nonadherence to 
study medication, (3) use of other health services, and (4) use of other medications. 
 We performed a manual backward stepwise regression process where all candidate 
variables (table II) were included in the initial model. Nonsignificant variables at the 
.05 level were subsequently removed to determine independent associations with 
non-adherence. We report the odds ratio (OR) and the 95% confidence interval (CI) 
for all variables that remained in the final model. 
A sensitivity analysis was conducted to assess the impact of worsening of symptoms 
in the first week (as defined above) on the results of the regression model. 
Regression coefficients were compared to assess the impact of this variable. To 
prevent overfitting and reduce random errors, we needed at least 10 participants per 
variable.31 With 15 baseline characteristics (variables) we needed at least 150 
participants. This study was performed on 1643 participants. 
 
Table II; Characteristics of the baseline variables used in the logistic 
regression model 
Characteristic n=  Value 
Days since onset of pain 1651 9.85 (9.94) 
Perceived risk of persistent pain, (0-10) 1648 4.55 (2.78) 
Presence of pain extending beyond the knee, n (%) 1646 323 (19.6) 
The number of days of reduced usual activity 1648 3.58 (5.86) 
Disability measured, (0-24) 1648 13.06 (5.50) 
Pain intensity, (0-10) 1650 6.26 (1.90) 
Back pain episode not compensable, n (%) 1644 1526 (92.8) 
No health insurance status, n (%) 1648 877 (53.2) 
Income level under $88,399 per year, n (%) 1610 1238 (76.9) 
Credibility score, (0-37) 1633 26.65 (6.43) 
Expectation score, (0-19) 1638 13.69 (3.75) 
Feelings of depression in the past week, (0-10) 1648 3.12 (2.93) 
Good sleep quality, n (%) 1649 826 (50.1) 
Number of previous episodes 1644 6.88 (15.17) 
Worsening in week 1, n (%) 1519 26 (1.7) 
Values are mean (SD) unless stated otherwise 
 
RESULTS 
 
Descriptive analysis 
The PACE trial included 1643 participants; 53% were male, mean pain intensity ± SD 
at baseline was 6.3±1.9 on a 0 to 10 scale and mean disability ± SD was 13.1 ± 5.5 
on a 0 to 24 scale (table III). The mean number of days since onset of pain was 
9.9±9.9; 36.7% of the participants recovered within 1 week and 84.4% within 4 
weeks.  
 
 
 
 Table III; Episode characteristics over the first four weeks 
Characteristics Baseline (N = 1653) 
Week 1  
(N = 1519) 
Week 2  
(N = 1510) 
Week 4  
(N = 1515) 
Pain intensity, (NPRS, 0-10) 6.26 (1.90) 3.70 (2.62) 2.60 (2.54) 1.70 (2.35) 
Recovery (GPE, -5 to 5) -0.05 (2.11) 2.04 (2.16) 2.79 (2.13) 3.41 (2.09) 
Worsening of symptoms, N (%)  N/A 26 (1.7) 15 (1.0) 11 (0.7) 
Values are means (SD) unless stated otherwise, RDQ = Roland Moris Disability 
Questionnaire, NPRS = Numeric Pain Rating Scale, GPE = Global Perceived 
 
Overall early nonadherence was 39.7% in the first week, and overall 4-week 
nonadherence was 70.0%. Early nonadherence to study medication was 30.6%, 4-
week nonadherence was 57.5%. Early nonadherence due to use of additional 
treatments in the first week was 15.9%, 4-week nonadherence due to the use of 
additional medication was 14.2%, and 25.3% used additional health care. Less than 
2% of the participants reported worsening in the first week and there were no 
differences in nonadherence rates in the sensitivity analysis (table IV). 
 
Table IV; Nonadherence over the first week and first four weeks of the PACE 
trial* 
    Early Four-week  
 Characteristics nonadherence  non-adherence 
Non-adherence    Overall non-adherence, N (%) 608 (39.7) 1049 (70.0) 
  Use of other treatment, N (%) 247 (15.9) NA 
  Use of other health services, N (%) ND 388 (25.3) 
  Use of additional medication, N (%) ND 217 (14.2) 
  Following study medication protocol, N (%) 482 (30.6) 888 (57.5) 
     Non-adherence, adjusted for worsening;   Overall non-adherence, N (%) 589 (38.6) 1028 (69.6) 
  Use of other treatment, N (%) 231 (15.0) NA 
  Use of other health services, N (%) ND 368 (24.3) 
  Use of additional medication, N (%)  ND 203 (13.4) 
  Following study medication protocol, N (%) 472 (29.9) 888 (57.5) 
 
 
Multivariable logistic regression analysis  
Variables that remained significant in the final multivariate logistic regression models 
for overall 4-week nonadherence were higher perceived risk of persistence (OR, .93; 
95% CI, .89-.97), lower baseline disability (OR, 1.05; 95% CI, 1.05-1.07) and 
participants not claiming workers’ compensation (OR, .46; 95% CI, .27-.77) (Table 
V). Outcomes for separate aspects of 4-week nonadherence (study medication, 
additional medications and additional health care use) are presented in tables 6 to 8. 
Worsening of symptoms in the first week was associated with using additional 
 healthcare (OR. 6.10; CI, 2.57 to 14.46) and using additional medication (OR, 5.78; 
95% CI, 2.41-13.81) but not with nonadherence to the study medication. 
 
Table V; Results of the multi regression analysis for overall nonadherence 
over four weeks 
 Characteristic OR (95% CI) 
Perceived risk of persistent pain, (0-10) 0.93 (0.89-0.97) 
Disability measured, (0-24) 1.05 (1.05-1.07) 
No workers compensation 0.46 (0.27-0.77) 
 
Table VI; Results of the multi regression analysis for study-medication 
nonadherence over four weeks 
 Characteristic OR (95% CI) 
No health insurance 1.37 (1.11-1.68) 
Days of pain 0.98 (0.97-0.99) 
Perceived risk of persistent pain, (0-10) 0.90 (0.87-0.94) 
Disability measured, (0-24) 1.03 (1.01-1.05) 
No workers compensation 0.59 (0.38-0.90) 
 
Table VII; Results of the multi regression analysis for using additional 
healthcare over four weeks 
 Characteristic OR (95% CI) 
Number of days of reduced usual activity 1.03 (1.01-1.05) 
Pain intensity, (0-10) 1.11 (1.04-1.19) 
No workers compensation 0.42 (0.28-0.65) 
No health insurance  0.49 (0.39-0.63) 
Worsening in the first week 6.10 (2.57-14.46) 
 
Table VIII; Results of the multi regression analysis for using additional 
medication over four weeks 
 Characteristic OR (95% CI) 
Pain intensity, (0-10) 1.23 (1.13-1.35) 
Worsening in the first week 5.78 (2.41-13.81) 
No health insurance 0.73 (0.54-0.99) 
Presence of pain extending beyond the knee 0.66 (0.46-0.64) 
Expectancy score (3-27) 0.95 (0.91-0.98) 
 
DISCUSSION  
 
Summary  
In the first week of treatment almost 40% of the participants were non-adherent with 
the recommended care. Over the 4-week treatment period, 70.0% of participants 
were nonadherent. Failure to comply with the study medication regimen was the 
main contributor to nonadherence over the early and 4-week periods. Higher 
 perceived risk that symptoms will be persistent; lower baseline disability and 
participants not claiming workers’ compensation were independently associated with 
4-week overall non-adherence. Worsening in the first week was strongly associated 
with using additional healthcare or medication. 
Patient nonadherence in this study was high, despite the fact that participants were 
well informed and received regular prompts from study personnel. This shows that 
even recommending simple treatments to patients with LBP requires close 
monitoring and better support strategies may be required to increase adherence to 
treatment recommendations. 
The results also show that many participants access other treatments despite 
recommendations that these are not useful. In our study just over 25% of the 
participants used additional healthcare over the 4-week period. It is not clear why 
participants did not take the study medication as advised, or used additional tests or 
treatment. Specifically, it is unknown whether participants requested additional tests 
or accessed the treatment themselves, or clinicians advised participants to do so. 
Several studies suggest that typical adjunct treatments and tests provided to patients 
with acute LBP (eg. massage, acupuncture, McKenzie treatment, diclofenac or 
manipulative therapy treatments) do not improve outcomes in these participants.10–
12,32,33 Given the fast recovery rate of participants in the study (median time to 
recovery of 17d), the high rate of ancillary treatments would seem particularly 
unnecessary. Understanding why patients elected to use additional health care, 
medications and tests, even when well informed of their limited value, could be 
important to inform strategies to reduce excessive cost of low back pain 
management. 
 
Strengths and limitations 
Our study is based on a large dataset, collected in primary care. The GPs and study 
personnel gave all participants the same advice about the study treatment. 
Medication usage was self-reported through a diary and confirmed through 2 other 
methods. We also collected healthcare utilisation measurements at several different 
time points to improve reliability of these data. 
The fact that the outcomes were self-reported (use of other treatment, health 
services or additional medication) might be considered a limitation. Further, despite 
the training and instructions that trial GPs received, their adherence to the study 
protocol is unknown. For participants who underwent additional tests and treatments, 
or who used other medications, we do not know why, or who initiated the decision. In 
some cases, a participant could have been complying with the GP’s advice to use 
additional treatments. Also we do not know about adherence to all components of 
the treatment recommendations, (eg. the advice to stay active and avoid bed rest). 
Finally, we were unable to evaluate various other factors that might have an impact 
on patients’ adherence, as this was not the primary aim of the original study (PACE 
 trial). The factors included in our analysis are the ones that were gathered in the 
PACE trial. 
 
Comparison with existing literature 
The rate of nonadherence to study medication is not dissimilar to that of other trials. 
In a randomised controlled trial (RCT) of patients with acute LBP, adherence to at 
least 75% of prescribed medications was 54% for diclofenac and 48% for 
paracetamol.10 Another randomized controlled trial of patients with chronic LBP 
found much higher adherence to Duloxetine (80% - 120% of the recommended dose 
of one pill per day) of 85-93%.34 Our threshold was lower at 70% with a dosage that 
was higher (6 pills a day). However we asked the participants in our study to use 
paracetamol on a time-contingent basis, which is a factor known to be related to 
nonadherence.21,23  
With respect to concomitant healthcare, 1 randomized controlled trial comparing 
manipulative therapy with diclofenac reported that 12% of the patients with acute 
LBP used additional interventions.10 Other studies have found that 3% to 25% of new 
patients with LBP received diagnostic imaging.35,36 A comparable proportion of 
participants in our study used other therapies or tests in the first 4 weeks. Use of 
concomitant analgesics in our study (14%) was higher than that in another 
paracetamol study (3%).37  
The influence of baseline characteristics on nonadherence was not consistent with 
previous studies. Characteristics reported in other studies where either not 
significantly related (age, gender, baseline disability and perceived health) or 
unavailable in our dataset (fear of side effects, limited English proficiency, lack of a 
social support or forgetfulness).19–23 
 
Implications for research and/or practice 
This study gives insight into patient nonadherence to guideline-recommended care 
for acute LBP, and some of the factors associated with non-adherence. The results 
suggest adherence to simple and clear instructions, especially regarding medication 
usage, is poor in this population. More research into the complex nature of 
nonadherence is required to understand why patients do not comply with this advice. 
Future research could include interviews with patients to better understand their 
reasons for nonadherence.  
 
CONCLUSION 
 
When given guideline-recommended care consisting of simple analgesics, 
reassurance and physical advice, patients with acute LBP tend to not adhere to the 
recommended regimen of prescribed paracetamol and to refrain from using extra 
health services and additional medication. This study found that a lower baseline 
 disability and participants not claiming workers’ compensation contribute to patients’ 
non-adherence.   
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 ABSTRACT  
 
Objective:  
The purpose of this study was to translate and to investigate the reliability and 
validity of the STarT Back screening tool (SBT) in the primary care setting among 
patients with nonspecific low back pain (LBP). 
 
Design: 
The SBT was formally translated into Dutch following a multistep approach for 
forward and backward translation. General practitioners and physical therapists 
included patients with LBP.  
 
Methods: 
Patients completed a baseline questionnaire and a follow-up at 3 days and 3 
months. The construct validity was calculated with Pearson’s correlation coefficient. 
The reproducibility was assessed using the quadratic weighted kappa and the 
specific agreement. Predictive validity was assessed using relative risk ratios for 
persisting disability at 3 months. Content validity was analyzed using floor and ceiling 
effects.  
 
Results: 
In total, 184 patients were included; 52.2% were categorized in the “low-risk” 
subgroup, 38.0% “medium-risk,” and 9.8% “high-risk.” For the construct validity we 
found, as expected, a moderate to high Pearson’s correlation for questions 3 to 9 
and a low correlation for questions 1 and 2 with their respective reference 
questionnaires. The reproducibility had a quadratic weighted kappa of 0.65 and the 
specific agreement of 82.4% for “low-risk,” 53.3% for “medium-risk,” and 33.3% for 
“high-risk.” For the predictive validity for persisting disability we found a relative risk 
ratio for “medium-risk” of 1.8 (95% confidence interval [CI]: 1.0–3.1) and 2.7 (95% CI: 
1.4–4.9) for “high-risk” compared with “low-risk.” For the content validity, we found 
that no floor and ceiling effects were present.  
 
Limitations 
There was a relatively small sample size for the retest reliability study. Patients were 
not compared between physical therapist and GP, as there were not enough patients 
in both groups. For practical reasons, the patients filled out the baseline ques-
tionnaire after receiving the first treatment/consultation; however, the questionnaire is 
intended to be filled in before the first consultation/treatment.  
 
 
 
 Conclusion: 
The SBT has been successfully translated into Dutch. The psychometric analysis 
showed acceptable results and, therefore, the SBT is a valid screening tool for 
patients with LBP in Dutch primary care.  
 
 
 
  
 BACKGROUND 
 
Low back pain (LBP) is a major public health problem. Globally it is the most 
prevalent musculoskeletal disorder causing disability.1 In the Netherlands the point 
prevalence of LBP is found to be 26.9%.2 LBP is a condition that is broadly divided 
into three major subgroups. First, LBP with a specific (serious) underlying pathology, 
such as: tumors, fractures and infections. Second, LBP caused by nerve root 
compression as a result of a stenosis or herniated disc. The third group, the majority 
of people with LBP (85 - 90%), is called non-specific LBP as no cause can be 
found.3,4 Despite the fact that non-specific LBP is regarded self-limiting as it often 
resolves within 6 weeks, more recent prognostic studies concluded that for ~40% of 
patients with LBP recovery will take longer than 12 weeks.4–6 LBP is a burden on the 
health care system consuming in the Netherlands between €385-€455 million in 
direct medical costs and between €3-€3.1 billion in indirect costs 7 In the United 
States reports on combined direct and indirect costs for LBP vary between $86 billion 
and $238 billion.8–10  
Although it has been suggested that patients with non-specific LBP are not a 
homogeneous patient group, defining subgroups is challenging but important for 
targeting treatment to the individual patient.3,11,12 So far sub-grouping based on a 
patho-anatomical source of the pain appears to be of limited value because often an 
anatomical structure as cause of pain cannot be found.4 Certain psychosocial factors 
are known to influence patients’ recovery. Subgrouping patients based on 
psychosocial factors may result in successful risk stratification. The Keele STarT 
Back Tool (Subgroups for Targeted Treatment) (SBT) is a tool using different 
function, psychosocial and comorbid factors for subgrouping. It is developed in 
England, to allocate primary care patients with LBP into three subgroups concerning 
their prognosis: low, moderate or high risk for persisting disability13 and to apply the 
appropriate stratified care.14  
The SBT consists of 9 questions, 8 true/false questions and 1 question with a 5-point 
Likert scale as answer option. The validity of the SBT is often studied using a 
principal component factor analysis. In the United Kingdom (UK) study, as well as 
the Finnish, French, German and Persian studies it resulted in 2 subscales: 
biological (question 1 to 4) and psychosocial (question 5 to 9).13,15–18 The 
psychosocial subscale is then viewed as a distress subscale with a Cronbach’s 
alpha ranging from 0.52 (Finnish), 0.55 (German), 0.72 (UK), 0.74 (French), and 
0.81 (Persian).13,15–18 The discriminant validity has been determined by calculating 
the area under the curve (AUC) of the overall score with the Roland Disability 
Questionnaire (RDQ) (0.76-0.92).13,16 The psychosocial subscale of the Pain 
Catastrophizing Scale (PSC) (0.70-0.83) or the Tampa Scale of Kinesiophobia (TSK) 
(0.81).13,18 Other studies calculated the AUC for each separate question resulting in 
AUCs ranging from 0.74 to 0.86.16,19 The SBT is a questionnaire formed by 
combining known factors for delayed recovery of back pain. Based on these 
 independent factors it aims to predict poor disability with each factor adding to the 
likelihood of a poor prognosis, this is called a formative model. In our formative 
model approach it is unnecessary to calculate internal consistency and the AUC 
against the overall score or the psychosocial subscale as we approach it as 
independent factors and not as a coherent factors.  
The SBT’s ability to predict poor disability at 6 months had sensitivity scores ranging 
between 39.6% and 80.1% and the specificity scores ranging from 65.4% to 
94.6%.13 The English SBT has been found to be a reliable tool in the UK with a 
quadratic weighted kappa of 0.79.13 It has been translated in several languages 
since its initial English publication in 2008.16–22 No study has been published on the 
SBT to evaluate the validity and reliability in Dutch primary healthcare. Our aim is to 
evaluate the validity and reliability of the STarT Back Tool Dutch Version in Dutch 
primary care. 
 
METHOD 
 
Translation of the SBT 
The original SBT13 (Appendix A and B) was formally translated following the 
multistep approach of Beaton et al.23 and the guidelines of Streiner and Norman.24 
Two Dutch native speakers independently performed a forward translation. After 
synthesis of a draft Dutch translation of the SBT, this version was backward 
translated into English by both a Dutch and an English native speaker. An expert 
committee was formed consisting of one translator who is also a clinical 
epidemiologist, one backward translator and one clinician (orthopedic spine 
surgeon). The group examined the forward and backward translations and 
consolidated these to produce a “pre-final” version of the Dutch SBT. As it became 
apparent that two different study groups were preparing Dutch translations a second 
expert meeting, consisting of a representative of each study group (R.O. and M.vH.) 
was held. A “combined pre-final” version was compiled based on all previous 
documents and differences were resolved through consensus. The only difference 
was found in the translation of question 1 “spread down my leg(s)”. We discussed 
whether to use ‘naar één of beide benen’ (ie. “to one or both legs”) or “naar mijn 
benen” (ie. “to both legs”). As in the original English version the “s” of “legs” is written 
between brackets, consensus was reached to use “naar één of beide benen” (ie. “to 
one or both legs”) in the “combined pre-final” version. 
 
Pre-final testing 
To test the “combined pre-final” version, 20 consecutive Dutch-speaking patients 
with LBP at the outpatient department of a secondary and tertiary spine referral 
center, completed this version.  In addition, a possibility was made to give comments 
and suggestions to improve. After completion, they were briefly interviewed about 
 their thoughts of what was meant by each question and the chosen answer. They 
were also asked for their general comments on the questionnaire (eg. lay-out, 
wording, ease of understanding and completion, ambiguities). As no further 
comments or suggestions to improve were given, the expert group upgraded the 
‘pre-final’ version to the final version. 25 The Dutch version of the SBT is found in 
Appendix A and B 
 
Design  
The final translated version was subsequently used in this clinimetric study as part of 
a prospective cohort (PRINS study; Prevalence of RIsk groups in Neck- and back 
pain patients according to the STarT back screening tool) including patients with LBP 
(and neck pain for a parallel study) of any duration in primary care. This is the first 
article published on this cohort. Patients received regular care by their general 
practitioner (GP) or physical therapist. In the Netherlands patients have direct access 
to physical therapist care and therefore this is regarded primary care as is GP-care. 
Patients were asked to answer baseline and follow-up questionnaires. A power 
analysis power showed that 100 patients were needed for a reliability study. The 
study was approved by the medical ethics committee of the Erasmus University, 
Rotterdam, The Netherlands. (MEC-2014-256). For this study we only use the data 
of the LBP patients of the PRINS-cohort. 
 
Participants 
General practitioners and physical therapists.  
We asked GP’s and physical therapists that had previously showed their interest in 
the SBT to participate in the study and asked them to invite colleagues. Information 
about the study protocol was given through several meetings, by phone, or by 
digital/paper documentation. Participating GP’s and physical therapists received the 
study protocol and a folder with patient information brochures and informed consent 
forms.  
 
Patients 
The inclusion period for patients started November 2014 to May 2015. When a 
patient consulted their GP or physical therapist for their back pain they were asked to 
participate in the PRINS study. Other inclusion criteria were that the patient was 18 
years or older, could speak, read and write in Dutch and had an email address. 
Patients were excluded if during the consultation the GP or physical therapist found 
red flags indicating a possible specific underlying pathology (eg. infection, fracture, 
cauda equina or tumor) responsible for the LBP.  
Patients were given oral and written information about the procedure of data 
collection and the aim of the study. They were given an informed consent form. 
When the patient signed the informed consent form and handed it back to their GP or 
physical therapist they registered the patient online. The patient immediately 
 received an email with a link to the baseline questionnaire. When necessary a 
reminder was sent within a few days.  
 
Treatment 
The clinician was blinded for the results of the questionnaires including the score on 
the SBT. The patients received usual care by their GP or physical therapist. We 
asked the clinician to treat their patient according to their guideline. The guideline 
advises the GP provide advice and, if necessary, analgesics to patients in the acute 
phase. In case of persisting pain GPs can refer the patient to the physical therapist. 
Guideline recommendations for Physical therapists differ based on the course of 
pain. In a normal course of pain the physical therapist is advised to give reassurance 
and information to the patient. In case of an abnormal course of pain the physical 
therapist should provide evidence based interventions such as exercise therapy, 
mobilization, manipulation and/or massage.26,27 
 
Measurements  
Baseline 
At baseline (T0) patients filled out a questionnaire consisting of demographic 
variables (eg. age, sex) and the SBT. Furthermore, we measured the average pain in 
the past week using the 11-point Numeric Pain Rating Scale (NPRS)28 ranging from 
0 (no pain) to 10 (worst imaginable pain). Disability was operationalized using the 
RDQ29,30 consisting of 24 statements with a “yes” or “no” answer option. The total 
score ranges from 0 to 24, a higher score indicating more disability. We measured 
Fear of movement/(re)injury using the TSK31 consisting of 17 statements with four 
answer options varying from “highly disagree” to “highly agree”. The total score 
ranges from 17 to 68, a higher score indicating a higher level of kinesiophobia. To 
assess the level of catastrophizing we used the PCS, which consists of 13 
statements with each a 5-point Likert scale answers option ranging from “not at all” 
to “always”.32 The total score ranges from 0 to 52, a higher score indicating a higher 
level of catastrophizing. Finally we assessed quality of life using the EQ-5D33 
consisting of six questions. The first five questions have a 3-point Likert scale 
answer options ranging van “no problems” to “severe problems” and the sixth 
question is a health status question ranging from “worst imaginable health” to “best 
imaginable health”, score ranges from 0 to 100.  
 
Follow-up 
Three days after inclusion (T1) a repeat-questionnaire was sent in order to 
investigate the retest reliability of the SBT. It consisted of the SBT, the NPRS and the 
General Perceived Effect (GPE) scale to measure recovery: “To what degree have 
you improved since filling out the baseline questionnaire?” The answer options range 
from “fully recovered” to “worse than ever” on a 7-point likert scale. The time interval 
was considered long enough to reduce recall bias and short enough to prevent 
 substantial improvement.34 This repeat-questionnaire was send to patients that were 
included during the last 3 months of the inclusion period.  
Three months after inclusion (T2), the patients received a follow-up questionnaire 
consisting of the GPE and RDQ. At the same time we sent a questionnaire to the GP 
to ask about the number of visits, prescribed medication, referrals to physical 
therapistor medical professionals and requested diagnostic imaging and blood tests. 
We sent a similar questionnaire to the physical therapist to ask about treatment data 
such as date of first and last treatment, number of treatments, questionnaires used 
and the aim and means of treatment. All questionnaires were handled and stored 
though LimeSurvey 2.05 (Lime Survey GmbH, Hambrug, Germany) 
 
Statistical analysis 
First we analyzed the data to describe the characteristics of the GP’s, physical 
therapists and the patient population using frequencies, means and standard 
deviations. The prevalence of the 3 risk profiles according to the SBT-scores are 
reported 
For the construct validity we first analyzed at the characteristics across SBT risk 
profile to determine the discriminant validity. Next, we calculated the Pearson’s 
correlation coefficient between specific items of the SBT and their respective 
reference questionnaires based on the comparability of the domains of 
measurement.35,36 A priori we expected a moderate (r ≥ 0.3, <0.5) to high (r ≥ 0.5) 
correlation between the SBT activity-questions 3 and 4 with the RDQ, kinesiophobia-
question 5 with the TSK, catastrophizing-question 6, 7 and 8 with the PCS and the 
bothersome-question 9 with the NPRS. We expected a low correlation (r < 0.3) 
between question 1 and 2 and the NPRS as these focus on the location of the pain 
and not the intensity of pain. 
We calculated the reproducibility (evaluating the agreement between 2 
measurements) in the patient group that remained stable between baseline (T0) and 
T1. We asked the patients after 3 days to fill out the questionnaire a second time. 
Patients were considered stable when they scored “slightly improved”, “no change” 
or “slightly worsened” on the GPE at second measurement. As there is some doubt 
in the literature whether the GPE actually can detect change, we combined the 
stable GPE score with a stable pain score meaning the NPRS on T1 was plus or 
minus one point compared to baseline.3 We calculated the quadratic weighted kappa 
and the specific agreement. The quadratic weighted kappa will be interpreted as ≤0 
= poor agreement; .01–.20 = slight; .21–.40 = fair; .41–.60 = moderate; .61–.80 = 
substantial and .81–1 = almost perfect agreement.37 The specific agreement is 
calculated for each risk profile separately.35 For example; patients who are “low-risk” 
on baseline and follow-up are calculated as a proportion of patients that were “low-
risk” on either of the two measurements. In collaboration with Henrika de Vet we 
modified the specific agreement to fit a 3 x 3 table as shown in table I because the 
original method is done in a 2 x 2 table. 
 Table I; Specific agreement 
    Follow-up (T1) 
  
Low Medium High 
Baseline (T0) Low 7 (A) 2 (B) 0 (C) 
 
Medium 1 (D) 4 (E) 0 (F) 
 High 0 (G) 4 (H) 1 (I) 
“Low-risk” A/(A+(B+C+D+G)/2) = 7/8,5 = 82.4% 
“Medium-risk” E/(E+(B+H+D+F)/2) = 4/7.5 = 53.3% 
“High-risk” I/(I+(C+F+G+H)/2) = 1/3 = 33.3% 
 
We determined the predictive validity by reporting the relative Risk Ratio (RR) for 
“medium-risk” and “high-risk”, both compared to “low-risk” in their ability to predict 
the outcome on three months. We defined persisting disability as a RDQ of ≥7, this is 
equal to the cut-off used in the original study where it was the median of the baseline 
scores.13 Persisting pain is defined as a NPRS above the baseline median and 
recovery is defined as either “completely recovered” or “much improved” on the GPE. 
Limited content validity is indicated by the presence of more than 15 percent of the 
patients reached either the floor (0/9 points) or ceiling effects (9/9 points) on the 
SBT.34 
To measure the construct validity and reliability a sample size of at least 50 persons 
is advised.34 
 
Figure I, patient flow 
 
 
 
 
 RESULTS 
Patient population 
In total, 41 GPs and 70 physical therapists signed up to participate and 12 GPs and 
33 physical therapists actually included patients. They included 370 patients of which 
184 with LBP and 100 with neck pain for the parallel study, 86 patients did not fill out 
the baseline questionnaire and were excluded from the analysis. Loss to follow up at 
three months was 34 (18%) (Figure I). Patients that were lost to follow up showed 
comparable baseline characteristics compared to the responders. Of the LBP 
patients, at baseline 96 (52%) patients were categorized as “low-risk”, 70 (38%) as 
”medium-risk” and 18 (10%) as ”high-risk” (table II). We found no differences 
between the groups concerning age, gender of whether they were included by the 
GP or physical therapist. 
 
Validity and reproducibility  
Construct validity 
For each increase in the risk profile we found a corresponding increase in pain, 
disability, catastophising and kinesiofobia (Table III) showing that the SBT has good 
discriminant validity. Next we found a high correlation, between SBT question 9 and 
the NPRS (r = 0.6), question 3 and 4 with the RDQ and question 8 with the PCS (all r 
= 0.5). We found a moderate correlation (r = 0.4) between question 5 and the TSK 
and question 6 and 7 and the PCS (both r = 0.3). The correlation between question 1 
and 2 was absent to low and scored r = 0.28 and r = -0.05 respectively (Table IV). 
The correlations are as was expected a priori and therefore we conclude that the 
construct validity is good.  
 
Reproducibility  
The average time between first (T0) and second (T1) questionnaire was 6 days 
(range 3-10). In total, 58 patients completed the second questionnaire of which 19 
patients were regarded stable compared to baseline. The quadratic weighted kappa 
for the SBT of 0.65 (95% CI: 0.34 – 0.96) showed a substantial reproducibility. The 
“low-risk” group had a specific agreement of 82.4%, “medium-risk” of 53.3% and 
”high-risk” of 33.3% showing an excellent to fair reproducibility. 
 
  
 Table II; baseline characteristics of the study population 
    Study population 
UK-validation 
sample 
    (n=184) (n=500) 
Female 103 (56.0) 293 (58.6) 
Age in years, mean (SD) 44.6 (14.6) 45 (9.7) 
SBT risk profile     
  Low 96 (52.2) 234 (47.4) 
  Medium 70 (38.0) 186 (37.7) 
  High 18 (9.8) 74 (15.0) 
Episode duration     
  <1 month 53 (28.8) 83 (16.9) 
  1 to 3 months 26 (14.1) 94 (19.1) 
  4 to 6 months 12 (6.5) 77 (15.7) 
  7 months to 3 years 36 (19.6) 125 (25.5) 
  >3 years 57 (31.0) 112 (22.8) 
SBT score, mean (SD) 3.60 (2.0) 3.83 (2.3) 
Pain intensity     
  Mild (0-5) 63 (34.2) 325 (66.1) 
  Moderate (5-7) 88 (47.8) 113 (23.0) 
  Severe (8-10) 33 (17.9) 54 (10.1) 
Disability (RDQ), mean (SD) 9.5 (5.9) 9.1 (5.9) 
Referred leg pain 54 (29.3) 303 (60.6) 
Comorbid pain in neck/shoulder 124 (67.4) 276 (55.2) 
Very or extremely bothered by back 94 (51.1) 276 (55.2) 
Fear (TSK), mean (SD) 34.8 (7.1) 39.5 (6.9) 
Catastrophizing (PCS), mean (SD)  13.7 (10.3)   
Values are numbers (percentage) unless otherwise indicated. SBT = STarT Back 
Tool (0-9), RDQ = Roland Disability Questionnaire (0-24), TSK = Tampa Scale of 
Kinesiophobia (17-68), PSC = Pain Catastrophizing Scale (0-42). Pain intensity is 
measured on a Numeric Pain Rating Scale (0-10). UK Validation study preformed by 
Hill in 200813 
 
Predictive validity  
In total 150 patients completed the T2 questionnaire, of which 76 were regarded as 
“low-risk” at baseline, 58 as “medium-risk” and 16 as “high-risk”. In all 3 risk profiles 
a decrease in NPRS and RDQ scores over time was seen. The number of patients 
with a decrease that met the threshold (RDQ < 7) was highest in the “medium-risk” 
group (Table V). Persisting pain is set as a NPRS ≥ 6. The RR for “medium-risk” at 
three months as compared to the “low-risk” were 1.8 (95% CI: 1.0 – 3.1) for 
persisting disability, 1.6 (95% CI: 0.9 – 3.0) for persisting pain and 1.0 (95% CI: 0.7 – 
1.3) for recovery.  For “high-risk” compared to the low-risk group the RR were 2.7 
 (95% CI: 1.4 - 4.9) for persisting disability, 3.4 (95% CI: 2.3 – 6.8) for persisting pain 
and 0.6 (95% CI: 0.3 – 1.2) for perceived recovery. An RR of 3.4 means that patients 
with “high-risk” had 3.4 times higher chance for persisting low back pain compared to 
patients with “low-risk”. Some confidence intervals include 1 (= equal risks) making it 
statistically insignificant.  
 
Content validity  
We analyzed 184 baseline questionnaires concerning the SBT in determining floor 
and ceiling effects. Nine patients (4.9%) scored zero and 2 patients (1.1%) scored 9 
points implying no floor or ceiling effects are present and therefore the SBT showed 
a good content validity. 
 
Table III, characteristics of patients in the risk profiles* 
 Characteristic Low risk Medium risk High risk 
SBT, N (%) 96 (52.2) 70 (38.0) 18 (9.8) 
RDQ 6.5 (4.9) 11.8 (5.1) 16.7 (3.1) 
NPRS 5.2 (1.8) 6.5 (1.5) 7.2 (1.6) 
TSK 32.4 (5.9) 35.4 (6.6) 44.6 (6.2) 
PCS 10.0 (7.9) 15.0 (9.5) 28.6 (10.6) 
Values are mean scores (SD) unless otherwise indicated. SBT = STarT Back Tool 
(0-9), RDQ = Roland Disability Questionnaire (0-24), NPRS = Numeric Pain Rating 
Scale (0-10), TSK = Tampa Scale of Kinesiophobia (17-68), PSC = Pain 
Catastrophizing Scale (0-52). 
 
Table IV; Pearson’s correlation between the STarT Back Tool and their 
reference questionnaires 
SBT and reference Correlation   
  A priori r   Expected 
Q1 - NPRS r < 0.30 0.28 low Yes 
Q2 - NPRS r < 0.30 -0.05 low Yes 
Q3 - RDQ r ≥ 0.30 0.48 moderate Yes 
Q4 - RDQ r ≥ 0.30 0.49 moderate Yes 
Q5 - TSK r ≥ 0.30 0.38 moderate Yes 
Q6 - PCS r ≥ 0.30 0.34 moderate Yes 
Q7 - PCS r ≥ 0.30 0.28 low No 
Q8 - PCS r ≥ 0.30 0.46 moderate Yes 
Q9 - NPRS r ≥ 0.30 0.63 high Yes 
r = Pearson’s correlation, NPRS = Numeric Pain Rating Scale, RDQ = Roland 
Disability Questionnaire, TSK = Tampa Scale of Kinesiophobia, PCS = Pain 
Catastrophizing Scale. 
 DISCUSSION 
 
Main findings  
The SBT is a formative model aiming to give a prognosis on poor disability. The 
construct validity showed correlations as a priori was expected between SBT items 
with their respective reference questionnaires (NPRS, RDQ, TSK and PSC). The 
retest reliability is moderate to good, and the RR demonstrates an increased chance 
for persisting disability and pain with an increase of the risk profile. An expert 
committee found the questions to be relevant and 20 patients used the SBT and 
comprehended all questions. Furthermore the absences of floor and ceiling effects 
confirmed a good content validity. 
  
Table V, Three month follow-up results 
  Persisting pain Persisting disability Recovery 
  NPRS (SD) 
RR  
(95% C.I.) 
RDQ 
(SD) 
RR   
(95% C.I.) 
GPE 
(SD) 
RR   
(95% C.I.) 
Low Risk  3.14 (2.38)   
3.67 
(5.09)   
2.28 
(0.89)   
Medium 
Risk 
3.38 
(2.64) 
1.59 
(0.85 - 2.96) 
5.34 
(5.79) 
1.80  
(1.04 - 3.11) 
2.53 
(1.17) 
0.96  
(0.72 - 1.29) 
High Risk 5.13 (2.68) 
3.39  
(2.31 - 6.76) 
9.19 
(7.54) 
2.67  
(1.44 - 4.93) 
2.56 
(0.96) 
0.63  
(0.33 - 1.22) 
Values are mean scores (SD) unless otherwise indicated. NPRS = Numeric Pain 
Rating Scale (0-10), RDQ = Roland Disability Questionnaire (0-24), GPE = General 
Perceived Effects (1-7) 
 
Interpretation of findings  
The specific agreement, as a measurement to determine the reproducibility, shows a 
fairly accurate intra-observer consistency for patients with a “low-risk” score. The 
accuracy decreases as the risk-profile increases. This might be due to the relatively 
low number of patients in this high-risk category. Also, in “high-risk” patients multiple 
psychosocial factors are present, which can be influenced during therapy by 
addressing an active health behavior and the unlikeliness of a serious underlying 
condition.38 The latter is probably less of influence as the questionnaire at baseline is 
given after the first treatment during which the psychosocial factors and the active 
health behavior are likely to have been addressed. Patients might have been 
influenced by this information during the primary consultation and therefor shifted 
from the “high-risk” to the “medium-risk” group before completing the baseline 
questionnaire.  A previous study suggests that assignment to a risk category 
following a short delay may more successfully predict final outcomes than when 
administered during initial assessment.39  
 For the reproducibility analysis the conditions (time, pain, perceived recovery) were 
set a priori to ensure ‘stable patients’. Due to the natural course of the pain, patients 
might be recovering between both measurements, shifting to a lower risk-profile and 
explaining the higher score in the “low-risk” group. The Kappa is influenced by a 
skewed distribution due to the large proportion of patients with “low-risk”. 
Nevertheless the Kappa shows that the SBT is able to distinguish sufficiently 
between risk groups.35 Within the reproducibility analysis we found that four out of 
the five patients shifted from “high-risk” to “medium-risk” within the first week. These 
patients had only one consultation in this period and therefore might have been 
susceptible to change.  
We used RR to calculate the additional risk of “high-risk” and “medium-risk” 
compared to “low-risk”. Predicting persisting disability gave the best results, in 
accordance with the developers aim. Poor disability is defined as a RDQ score of 7 
or more, like the original study and other comparable studies.13,15–18,38 When 
interpreting the predictive value it has to be taken into account that clinicians applied 
‘usual care’. There was no standardized or stratified therapy protocol for the 
clinicians to use. We asked the GP or physical therapist the follow the national 
guidelines, but recent studies show that guidelines are often not followed by the 
clinician or the patient.40,41 The clinician was free to apply their usual care and adjust 
their therapy in the way they seemed fit. 
The confidence intervals of the “medium-risk” and “high-risk” risks for persisting pain 
and disability show some overlap, which might suggest a lack of independence, but 
may also be the result of a lack of power. Furthermore, it has to be taken into 
account that clinicians applied “usual care” and not the advised approach possibly 
influencing the outcome, which might explain the overlap. 
 
Findings in the context of other literature 
When comparing our results with the results from the UK study we have to keep in 
mind that the healthcare system is different between the countries. Despite these 
differences, we included, in line with the UK study, all LBP patients disregarding 
duration of complaints or previously provided healthcare. In contrast to the UK study, 
in our study not all patients were seen by their GP as the physical therapist also 
included and treated patients via direct access. 
The distribution in risk-profiles in our study was well comparable with the distribution 
in the UK study.13 All other cohorts all had a shift towards “high-risk” at the expense 
of “low-risk”.16–19,21 For each increase in risk profile we found an increase in pain, 
PCS and TSK, this discriminant validity is also found in another studies.42–44 Other 
validation studies such as the Finnish, German, French, and Persian followed the 
same method as the initial UK study by using the Area Under the Curve (AUC) to 
determine the validity thus making it easier to compare.16,18 In our study we refrained 
from using the AUC because we chose not to dichotomize the scores of the 
questionnaires. We used the Pearson’s correlation coefficient giving us the 
 correlation information needed, although this made it more difficult to compare our 
results to other studies. We compared individual questions with their reference 
questionnaire; the UK study used the total SBT score or the psychosocial subscale 
to calculate the AUC.  
The quadratic weighted kappa for the retest reliability in our study is lower than the 
one in the UK study (0.79 for the stable patients), but comparable to the German 
version (0.67).13,18 This might be due to our small sample size of 19 compared to 295 
and 410 in the previous mentioned studies. Our data is also more skewed towards 
“low-risk” as a result of a higher percentage of patients in this group, which 
influences the kappa. Besides using the quadratic weighted kappa we also 
calculated the specific agreement.35 No other studies used this measurement 
therefore we can’t compare results. Our findings are in accordance with all other 
studies that evaluated translations of the SBT to be a reliable and valid 
instrument.13,15,16,18,19 
 
Strengths and limitations 
The strength of this study is that we successfully translated the SBT into Dutch and 
determined the construct validity, reproducibility, predictive validity and content 
validity. The advised minimum sample size was met for the validity section. A 
limitation is that we had a relatively small sample size for the retest reliability study. 
Also we were not able to compare patients between GP and physical therapist, as 
we did not have enough patients in both groups. Another limitation is that for 
practical reasons the patient filled out the baseline questionnaire after receiving the 
first treatment/consultation. The questionnaire is intended to be filled in before the 
first consultation/treatment because the patient might change its cognition and 
therefore influence the results. 
 
Clinical and/or research implications 
The STarT Back tool has been translated and validated for use in Dutch primary 
care. It can be used to, in an early stage, predict persisting disability. More important 
is that is can be used to match the patient to the advised treatment. Further research 
is needed to determine if this stratified care leads to a faster recovery and in its turn 
leads to lower healthcare consumption and lower costs. To further determine the 
predictive validity future studies might include a non-intervention (natural course) 
group. 
 
CONCLUSION 
 
The SBT is successfully translated in Dutch and according to the psychometric 
analysis it showed to be a sufficiently valid and reliable instrument. 
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 Appendix A; the original English version of the STarT Back Tool   
 
  
  
The Keele STarT Back Screening Tool 
 
 
Patient name: _______________________________    Date: _____________ 
 
 
 
 
Thinking about the last 2 weeks tick your response to the following questions: 
 
 
  Disagree Agree 
  0 1 
1 My back pain has spread down my leg(s) at some time in the last 2 weeks □ □ 
2 I have had pain in the shoulder or neck at some time in the last 2 weeks □ □ 
3 I have only walked short distances because of my back pain □ □ 
4 In the last 2 weeks, I have dressed more slowly than usual because of back pain □ □ 
5 It’s not really safe for a person with a condition like mine to be physically active □ □ 
6 Worrying thoughts have been going through my mind a lot of the time □ □ 
7 I feel that my back pain is terrible and it’s never going to get any better □ □ 
8 In general I have not enjoyed all the things I used to enjoy □ □ 
 
 
9.  Overall, how bothersome has your back pain been in the last 2 weeks? 
 
 
Not at all Slightly Moderately Very much Extremely 
□ □ □ □ □ 
0 0 0 1 1 
 
 
Total score (all 9): __________________   Sub Score (Q5-9):______________ 
 
 
 
 
 
                                                                                  © Keele University 01/08/07   
Funded by Arthritis Research UK
 Appendix B; the translated Dutch version of the STarT Back Tool 
 
 
  
This is a licensed tool (©2007 Keele University) that may not be modified.The copyright (©2007) of the STarT Back Tool and associated materials is 
owned by Keele University, the development of which was part funded by Arthritis Research UK: 
i) the tool is designed for use by health care practitioners, with appropriate treatment packages for each of the stratified groups; 
ii) the tool is not intended to recommend the use of any particular product. For further information please see http://www.keele.ac.uk/sbst/   
No license is required for non-commercial use.  If you would like to incorporate the Dutch version of the STarT Back Tool in any way into commercial 
product materials, please contact Miranda van Hooff for further advice. 
 
The STarT Back Screening Tool: Dutch Version 
Rugscreenings Instrument 
Auteur: M van Hooff,  W van Lankveld, P Anderson, A Apeldoorn, F van Hartingsveld, R Ostelo (2011) 
 
Naam: _______________________________     Datum: _____________ 
 
 
Antwoord u alstublieft ieder onderdeel. Kruis bij ieder onderdeel het vakje aan dat op u van 
toepassing is. Soms is het moeilijk om tussen twee vakjes te kiezen, kruis dan het vakje aan 
dat uw probleem het beste beschrijft. Kruis niet meer dan één vakje per onderdeel aan! 
 
Denk bij het beantwoorden van de volgende vragen telkens aan de situatie in de laatste 2 
weken. 
 
  Oneens Eens 
  0 1 
1 In de laatste 2 weken straalde mijn rugpijn wel eens uit naar één of beide benen.  □ □ 
2 In de laatste 2 weken heb ik wel eens pijn in mijn schouder of nek gehad. □ □ 
3 Vanwege mijn rugpijn liep ik alleen korte afstanden. □ □ 
4 In de laatste 2 weken kleedde ik me trager dan gewoonlijk aan vanwege mijn rugpijn. □ □ 
5 Voor iemand in mijn toestand is het echt niet veilig om lichamelijk actief te zijn. □ □ 
6 Ongeruste gedachten gingen vaak door mijn hoofd. □ □ 
7 Ik vind dat mijn rugpijn verschrikkelijk is en ik geloof dat het nooit meer beter zal worden. □ □ 
8 Over het geheel genomen heb ik niet genoten van alle dingen waar ik vroeger wel van genoot. □ □ 
 
 
9.  Over het geheel genomen, hoe hinderlijk was uw rugpijn in de laatste 2 weken? 
 
 
In het geheel 
niet Een beetje Matig  Erg Extreem 
□ □ □ □ □ 
0 0 0 1 1 
 
 
Totale uitslag (alle 9) : __________________ Sub Uitslag (Q5-9):______________ 
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pain in primary care 
 
 
 
Jasper D. Bier, Raymond W.J.G. Ostelo, Bart W. Koes, Arianne P. Verhagen 
 
 
 
Musculoskeletal Science and Practice, 2017  
 ABSTRACT  
 
Objective:  
To evaluate the reliability and validity of the Dutch version of the STarT Back 
screening Tool (SBT), for patients with neck pain. 
 
Methods:  
We modified the SBT to fit patients with neck pain. General practitioners and 
physiotherapists included patients who completed both a baseline and a follow-up 
questionnaire at 3 days and 3 months, respectively. The construct validity was 
assessed using Pearson’s correlation between the SBT and the reference 
questionnaires. The reproducibility was assessed in the first week using the 
quadratic weighted kappa and the specific agreement. Predictive validity was 
assessed using a relative-risk ratio (RR) for, amongst others, persisting disability at 3 
months. Content validity was analysed using both floor and ceiling effects. 
 
Results:  
In total, 100 patients were included; 58% were categorised as being at “low risk” for 
persisting disability, 37% at “medium risk” and 5% at “high risk”. As expected for the 
construct validity, we found a moderate to high correlation for all questions except for 
activity question 3. The reproducibility had a quadratic-weighted kappa of .58, and a 
specific agreement of 90.9% for “low-risk” and 66.7% for “medium-risk” patients. The 
RRs for persisting disability for “medium-risk” against “low-risk” patients were 1.5 
(95% C.I. 0.9 - 2.4) and 1.5 (95% C.I. 0.5 - 4.1) for pain. The sample size for high-
risk patients was low. 
 
Conclusion:  
The original SBT is modified to fit patients with neck pain in Dutch primary care. The 
psychometric analysis indicates sufficiently reliable outcomes, although the 
predictive validity showed statistically insignificant results. 
  
 BACKGROUND 
 
Globally, neck pain is the fourth largest musculoskeletal disorder causing disability.1 
Numbers from NIVEL, the Netherlands institute for health-services research, found 
that, in 2015, neck pain was the most prevalent disorder in Dutch physical therapy.2 
The estimated one-year incidence of neck pain varies between 10% and 21%.3 In 
patients with acute neck pain, pain and disability decrease in the first six weeks by 
approximately 45%; however, little or no decrease can be found afterwards.4 A Dutch 
cohort found that after one year, 76% of patients with neck pain reported to be fully 
recovered or much improved, indicating that, in many patients, complaints still persist 
over time and/or are recurrent.5 The annual cost of neck pain in the Netherlands was 
estimated to be $668 million in 1996; unfortunately, more recent data are not 
available.6 
The Neck Pain Task Force and the Dutch physiotherapists’ guideline on neck pain 
classify neck pain into four grades based on the following factors: interference with 
activities of daily living, the presence of neurological signs (grades I - III), or signs 
and symptoms of major structural pathology (grade IV).7,8 The course of the pain 
(normal or delayed recovery) often determines whether physiotherapeutic treatment 
is advised; when the course of the pain is normal, treatment is often not advised. 
Subgrouping patients is becoming an increasingly popular method for applying 
targeted treatment, since it has the potential to optimise treatment benefits and 
maximise healthcare efficiency. For low-back pain (LBP), the SBT is probably the 
best-known tool for subgrouping back-pain patients in primary care combined with a 
targeted treatment. The SBT focuses on the combination of limitations in patients’ 
activity and pain as well as several psychosocial factors known to influence patients’ 
recovery. It was developed to assign primary-care patients with LBP to one of three 
subgroups based on their prognosis—low, moderate or high risk for persisting 
disability—and to apply the appropriate stratified care.9,10 The SBT consists of nine 
questions: eight true/false questions and one question with a 5-point Likert-scale as 
the answer option. It aims to predict persisting disability based on these independent 
factors, with each factor adding to the likelihood of a poor prognosis. For each 
subgroup, a targeted treatment is advised. In short, “low-”, “medium-” and “high-risk” 
patients receive information and advice; in addition, both “medium-” and “high-risk” 
patients receive standardised physiotherapy to address symptoms and function, and 
“high-risk” patients also receive psychologically informed physiotherapy to address 
the psychosocial obstacles to recovery.11 The SBT has been validated for LBP in the 
UK9, and translated into several other languages, including Dutch.12–19 A few 
preliminary studies were performed for other musculoskeletal pain conditions, such 
as lumbar stenosis, knee pain, shoulder pain and neck pain; however, these findings 
are not ready for clinical implementation.20–22 Our aims are to modify the SBT for 
patients with neck pain, and to evaluate the validity and reliability of the modified 
SBT in Dutch primary care. 
 METHOD 
 
Developing the SBT-Neck 
The Dutch SBT for LBP was initially a combined SBT tool for both patients with neck 
pain and LBP.19 It was used as a basis for the neck version. Next, we performed a 
preliminary field test with two general practitioners (GPs) and one physiotherapist 
(PT) working in primary care to analyse the instrument’s feasibility in 140 patients 
with neck pain or LBP of any duration. Of the 140 patients, 24.3% experienced neck 
pain, 42.1% experienced back pain and 32.9% experienced both. We found that 
patients who suffered from both neck and LBP (n = 46), in particular, had difficulty in 
answering the questions: they could not distinguish between neck pain and LBP.  
During a subsequent expert meeting, we decided to return to the initial LBP version 
and develop a separate neck-pain version. In most questions, “back” was replaced 
with “neck” and radiating pain in the legs was modified to radiating pain in the arms. 
Question 3 was changed to “I have used my arms and neck less due to my neck 
pain” instead of “I have only walked short distances because of my back pain”. The 
changes were based on consensus in the working group. The Dutch SBT is included 
in Appendix 1. Appendix 2 illustrates the comparison between the original SBT, the 
Dutch neck-pain version and its English translation.  
 
Design  
We performed a clinimetric sub study—the prevalence of risk groups in neck- and 
back-pain patients study (PRINS)—as part of a prospective cohort according to the 
SBT.19 All patients that consulted primary care for low-back or neck pain were asked 
to answer both baseline and follow-up questionnaires, and received usual care from 
their clinicians. The study was approved by the medical ethics committee of the 
Erasmus University, Rotterdam, the Netherlands. (MEC-2014-256). For this study, 
we only utilise the data of the patients with neck pain (with or without concurrent 
back pain) from the PRINS cohort. 
 
Participants 
Clinicians 
We invited clinicians who had previously expressed interest in evaluating the SBT to 
participate in this study. They all attended a meeting in which the study was 
explained, and they received the study protocol. They also received posters, 
information brochures and informed-consent forms for the patients. 
 
Patients 
We included patients from November 2014 until May 2015. When a patient consulted 
a GP or PT through referral or direct access for their neck pain, they were asked to 
participate in the PRINS study. Patients with non-specific neck pain (grade I - III), 
and who were 18 years or older, could speak, read and write in Dutch, and had an 
 email address, were included. Patients were excluded if, during the consultation, the 
GP or PT found red flags indicating a possible specific underlying pathology (grade 
IV), for example, an infection, a fracture, cauda equina or a tumour. Patients were 
given oral and written information about the procedure of data collection and the aim 
of the study. When a patient was willing to participate, he or she signed an informed 
consent and handed it back to the clinician, who registered the patient online. The 
patient immediately received an email with a link to the baseline questionnaire. 
 
Treatment 
Patients received usual care from their clinicians, who were unaware of the results of 
the baseline questionnaire, including the SBT score. 
 
Measurements  
Baseline 
At baseline (T0), patients filled out a questionnaire consisting of demographic 
variables, such as age and gender, and the SBT-Neck. We measured the average 
pain in the past week using the 11-point Numeric Pain-Rating Scale (NPRS)23, 
ranging from 0=“no pain” to 10=“worst imaginable pain”. Disability was assessed 
using the Neck Disability Index (NDI)24, which consists of 10 statements with a 6-
point scale ranging from 0=“not limited” to 5=“completely limited”. The score was 
doubled to obtain a total score, ranging from 0 to 100, with a higher score indicating 
greater disability. We measured fear of movement or (re)injury using the Tampa 
Scale of Kinesiophobia (TSK)25, which consists of 17 statements with four answer 
options varying from 1=“highly disagree” to 4=“highly agree”. The total score ranges 
from 17 to 68, with a higher score indicating a higher level of kinesiophobia. To 
assess the level of catastrophising, we used the Pain Catastrophising Scale (PCS), 
which consists of 13 statements, each with a 5-point Likert-scale as an answer 
option ranging from 0=“not at all” to 4=“always”.26 The total score ranges from 0 to 
65, with a higher score indicating a higher level of catastrophising. Finally, we 
assessed quality of life using the EQ-5D27, which consists of six questions. The first 
five questions each have a 3-point Likert-scale answer option ranging from 1=“no 
problems” to 3=“severe problems”, and the sixth question is a health-status question 
with answer options ranging from 0=“worst imaginable health” to 100=“best 
imaginable health”.  
 
Follow-up 
Three days after inclusion (T1), a follow-up questionnaire was sent to the patients to 
investigate the reliability of the SBT-Neck. The questionnaire consisted of the SBT-
Neck, the NPRS and the General Perceived Effect scale (GPE) to assess pain and 
recovery, respectively, and the answer options on the GPE range from 1=“fully 
recovered” to 7=“worse than ever”. We considered 3 days short enough to prevent 
 questionnaires, to reduce recall bias.28 For practical reasons, the test-retest 
questionnaire was added only for patients that were included during the last 3 
months of the inclusion period.  
Three months after inclusion (T2), the patients received a follow-up questionnaire 
consisting of the GPE and NDI; we simultaneously sent a questionnaire to the GPs 
to inquire about the patients’ number of visits, prescribed medication, referrals to 
physiotherapists or medical professionals, and requested diagnostic imaging and 
blood tests. We sent a similar questionnaire to PTs to inquire about treatment data, 
such as the dates of the patients’ first and last treatments, the number of treatment 
sessions, any questionnaires used, and the aim and means of treatment.  
 
Sample size 
Terwee et al. advise a minimum sample size of 50 persons for all aspects of the 
clinimetric study; we aimed for a minimum of 100 persons.28 
 
Statistical analysis 
We analysed the data to describe patients’ characteristics, which were expressed 
using frequencies, means and standard deviations. The risk-profiles distribution and 
their characteristics are reported. For construct validity, we first analysed the 
characteristics across the SBT risk profile to determine the discriminant validity. 
Next, we calculated the Pearson’s correlation coefficient for each item of the SBT-
Neck and its reference questionnaire, based on the comparability of the domains of 
measurement.29,30 We expected a moderate (r ≥ .3, < .5) to high (r ≥ .5) correlation 
between the following items: the first question of the SBT-Neck and the single-item 
question on ‘referred pain’, the third and fourth activity items and the NDI, the fifth 
kinesiophobia question and the TSK, the sixth and seventh catastrophising questions 
and the PCS, and the ninth bothersome question with the NPRS. We included no 
reference questionnaire for the second question, and no questionnaire to measure 
depression (question 8).  
For reproducibility, we selected the patients that remained stable between T0 and 
T1. Patients were considered stable when they scored “slightly improved”, “no 
change” or “slightly worsened” on the GPE at T1. Since there is some doubt in the 
literature regarding whether the GPE can actually detect change, we combined a 
stable GPE score with a stable pain score measured on the NPRS—meaning the 
same score plus or minus one point compared to the baseline score.31 We calculated 
the quadratic-weighted kappa for the ability to distinguish between groups, and the 
specific agreement for each risk profile separately.29 The kappa will be interpreted as 
≤ 0 = poor agreement, .01 - .20 = slight, .21 - .40 = fair, .41 - .60 = moderate, .61 - 
.80 = substantial, and .81 - 1 = almost perfect agreement.32 For example, patients 
who are at “low risk” on T0 and T1 are calculated as a proportion of patients that 
were at “low risk” on either of the two measurements. In collaboration with de Vet, we 
 modified the specific agreement to fit a 3x3 table, as illustrated in table I, because 
the original method employs a 2x2 table. 
We determined the predictive validity by reporting the RR for “medium-risk” and 
“high-risk” patients, compared to those at “low-risk”, in their ability to predict the 
outcome at 3 months. The outcomes are 1) persisting disability, defined as an NDI 
equal to or higher than the median of the NDI on baseline, and 2) persisting pain, 
defined as an NPRS equal to or higher than the median of the NPRS on baseline, 
corresponding to the method that Hill used in the original study.9 For patients’ 
individual recovery we analysed 3) disability non-recovery—an NDI score that 
decreased to below the minimal clinically important difference (MCID) of 4 points33, 
4) pain non-recovery—an NPRS that decreased to below the MCID of 2 points34, and 
5) perceived recovery—defined as either “completely recovered” or “much improved” 
on the GPE.35 
Limited content validity is indicated by more than 15% of the patients reaching either 
the floor (0/9 points) or ceiling (9/9 points) effects of the SBT.28  
 
Table I; specific agreement 
    Follow-up (T1) 
  
Low Medium High 
Baseline (T0) Low 15 (A) 2 (B) 0 (C) 
 
Medium 1 (D) 3 (E) 0 (F) 
 High 0 (G) 0 (H) 0 (I) 
“Low-risk” A/(A+(B+C+D+G)/2) = 15/16.5 = 90.9% 
“Medium-risk” E/(E+(B+H+D+F)/2)= 3/4.5 =66.7% 
“High-risk” I/(I+(C+F+G+H)/2)=0 
 
RESULTS 
 
In total, 12 GPs and 33 PTs included 100 patients with neck pain in the PRINS study. 
Loss to follow up at 3 months was 7 (7%) (figure I). At baseline, we found that 58 
patients (58%) were categorised as “low risk”, 37 (37%) as “medium risk” and 5 (5%) 
as “high risk” (table 2). We found no differences between the risk groups concerning 
age or gender. For each increase in the risk profile, we found an increase in the pain, 
disability, catastrophising and kinesiophobia scores (see table II).  
Overall, PTs treated patients in line with the guideline on neck pain: applying 
mobilisation, utilising exercise therapy and providing information.8 GPs do not have a 
guideline on neck pain, and they referred 22 (out of 26) patients to a PT. In total, five 
patients were prescribed pain medication, one was referred for imaging, and two 
were referred to medical specialists due to persisting pain. 
 
 
 
 Figure I, patient flow 
 
 
Construct validity  
We found a low correlation between activity-question 3 and the NDI scores (r = .13); 
a moderate correlation between activity-question 4 and the NDI, kinesiophobia-
question 5 and the TSK, and catastrophising-questions 6 and 7 and the PCS; and a 
high correlation between SBT-question 1 and the single-item question (r = .55), and 
bothersome-question 9 and the NPRS (r = .50) (table III). All correlations were a 
priori, as expected, regarding the direction of the correlation and the magnitude, with 
the exception of activity-question 3. We conclude that the construct validity is 
sufficient.  
 
Reproducibility  
In total, 44 patients completed the second test-retest questionnaire, and 21 of them 
were regarded as stable. On average, there were 12 days between T0 and T1. 
The quadratic kappa of .58 for the SBT-Neck indicated a moderate reproducibility. 
Distribution is skewed due to the large proportion of patients at “low risk” and the 
absence of a stable “high-risk” group. For the “low-risk” group, we found a specific 
agreement of 90.9% and a 66.7% agreement for the “medium-risk” group. We were 
unable to calculate the specific agreement for the “high-risk” group as there were no 
patients in this ‘reproducibility sample’. The overall agreement indicated excellent 
reproducibility for the “low-risk” group and fair reproducibility for the “medium-risk” 
group. 
 
 
 
 
  
 Table II; baseline characteristics of the study population 
    Neck pain Low risk Medium risk High risk 
    (N=100) (N=58) (N=37) (N=5) 
Female 65 (65.0) 39 (65.5) 23 (62.2) 4 (80.0) 
Age in years, mean (SD) 45.6 (14.3) 45.5 (14.1) 44.8 (13.7) 52.8 (21.1) 
SBT risk profile         
  Low 58 (58.0)  NA  NA  NA 
  Medium 37 (37.0)  NA  NA  NA 
  High 5 (5.0)  NA  NA  NA 
Episode duration         
  <1 month 27 (27.0) 15 (25.9) 11 (29.7) 1 (20.0) 
  1 to 3 months 18 (18.0) 12 (20.7) 6 (16.2) 0 (0.0) 
  >3 months 55 (55.0) 31 (53.4) 20 (54.1) 4 (80.0) 
SBT score, mean (SD) 3.4 (1,8) 2.1 (0.8) 4.9 (0.9) 7.6 (1.1) 
Pain intensity, mean (SD) 5.5 (1.9) 4.7 (1.8) 6.6 (1.4) 7.0 (0.7) 
  Mild (0-5) 41 (41.0) 34 (58.6) 7 (18.9) 0 (0.0) 
  Moderate (5-7) 46 (46.0) 24 (41.4) 18 (48.6) 4 (80.0) 
  Severe (8-10) 13 (13.0) 0 (0.0) 12 (32.4) 1 (20.0) 
Disability (NDI), mean (SD) 28.2 (13.6) 22.0 (9.8) 34.6 (12.2) 57.8 (14.2) 
Referred pain 33 (33.0) 15 (25.9) 15 (40.5) 3 (60.0) 
Comorbid pain 69 (69.0) 36 (62.1) 28 (75.7) 5 (100.0) 
Bothersome 48 (48.0) 12 (20.7) 31 (83.8) 5 (100.0) 
Fear (TSK), mean (SD) 32.2 (5.9) 29.7 (4.9) 34.8 (4.3) 42.6 (6.9) 
Catastrophizing (PCS), 
mean (SD)  12.7 (10.0) 8.8 (7.3) 16.1 (8.7) 32.6 (15.2) 
Values are numbers (percentage) unless otherwise indicated. pain is measured on 
the Numeric Pain Rating Scale (0-10). SBT = STarT Back tool, NDI = Neck Disability 
Index (0-100), TSK = Tampa Scale of Kinesiophobia (17-68), PSC = Pain 
Catastrophizing Scale (0-65) 
 
 
 
 
 
 
 
 
 
 
 
 
 Table III; Correlation between the STarT Back Tool and their reference 
questionnaires using the Pearson’s correlation 
SBT and reference Correlation   
  A priori r 
 
Expected 
Q1 – single item r ≥ 0.30 0.55 high Yes 
Q3 - NDI r ≥ 0.30 0.13 low No 
Q4 - NDI r ≥ 0.30 0.37 moderate Yes 
Q5 - TSK r ≥ 0.30 0.42 moderate Yes 
Q6 - PCS r ≥ 0.30 0.46 moderate Yes 
Q7 - PCS r ≥ 0.30 0.35 moderate Yes 
Q9 - NPRS r ≥ 0.30 0.50 high Yes 
SBT = STarT Back Tool, Q = Question, r = Pearson’s correlation, NDI = Neck 
Disability index, TSK = Tampa Scale of Kinesiophobia, PCS = Pain Catastrophizing 
Scale, NPRS = Numeric Pain Rating Scale 
 
Predictive validity  
In total, 93 patients completed the T2 questionnaire. In all three risk profiles, we 
found a decrease in pain and disability over time (see table IV).  
We found that, with an increase in the risk-profile, patients experienced a higher level 
of pain and disability at 3 months. The baseline median scores for pain and disability, 
which were an NDI ≥ 13 and an NPRS ≥ 6, respectively, were used as a cut-off point. 
More patients experienced persisting pain or disability in the “medium-risk” group 
than in the “low-risk” group; however, in both groups, an equal number of patients 
experienced a significant decrease in pain and disability in 3 months.  
The “high-risk” group comprised a small sample size (N = 3), resulting in 
unrepresentative results. The RRs for the “medium-risk” group compared to the “low-
risk” group were 3.0 for persisting disability and 3.9 for persisting pain. An RR of 3.9 
means that patients at “medium risk” were 3.9 times more likely to experience 
persisting neck pain, compared to patients at “low risk”. The RR confidence intervals 
for patients’ individual recovery and perceived recovery all include 1 (= equal risks),  
making it statistically insignificant. 

  
Table IV; relative risk of pain, disability or recovery at three month follow-up 
Persisting pain is NPRS ≥ 6, persisting disability is NDI ≥ 13 "MCID in pain" is a 
decrease of < 2 points, "MCID in disability" is a decrease of < 14 points, Recovery is 
a GPE score of 1 or 2. MCIC = Minimal Clinical Important Change, GPE = General 
Percieved Effects (1-7), NPRS = Numeric Pain Rating Scale (0-10), NDI = Neck 
Disability Index (0-100) 
*N=3 for pain measure due to missing value  
 
Content validity 
We analysed the data of 100 patients concerning the SBT-Neck to determine floor 
and ceiling effects. One patient (1%) scored zero, and one patient (1%) scored nine 
points, implying no important floor and ceiling effects, and therefore, a good content 
validity. 
 
DISCUSSION 
 
Main findings  
The SBT-Neck is a formative model that aims to give advises for targeted treatment. 
The construct validity is sufficient, although activity-question 3 did not meet the 
expected a priori correlation with the NDI. For the test-retest reliability the specific 
agreement is moderate to almost perfect and the kappa is moderate. The absence of 
floor and ceiling effects confirmed a good content validity. However the predictive 
validity, based on the MCID, demonstrated statistically insignificant results. The 
results for the “high-risk” group are based on a too small population to draw 
conclusions. 
 
Interpretation of findings  
The specific-agreement analysis that was used to determine the reproducibility 
reveals highly accurate consistency for patients with a “low-risk” score; the accuracy 
decreases, although it is still good, for the “medium-risk” group. The conditions were 
set to ensure ‘stable patients’ based on time, pain and reported recovery. 
Unfortunately, patients took 12 days, on average, to respond, instead of the aimed 3 
days, and the delay in response, in combination with the ranges in pain (NPRS +/-1) 
and recovery (GPE ‘no change’ +/- 1), could result in patients improving slightly, and 
therefore, changing to a lower risk profile. This might explain the lower score in the 
specific agreement for the “medium-risk” group. In interpreting the kappa, we must 
  Persisting pain Persisting disability MCID in pain MCID in disablity Percieved recovery 
  N (%) NPRS (SD) RR (95% CI) N (%) NDI (SD) RR (95% CI) N (%) RR (95% CI) N (%) RR (95% CI) N (%) RR (95% CI) 
Low Risk 5 2.64   7 12.32   24   36   37   
 (N=55) (9.1) (1.94)   (12.7) (9.60)   (43.6)   (65.5)   (67.3)   
Medium Risk 12 4.26 3.88 13 22.00 3.00 15 0.99 17 1.45 16 0.70 
 (N=34) (35.3) (2.59) (1.50 - 10.06) (38.2) (15.04) (1.33 - 6.78) (44.1) (0.68 - 1.45) (50.0) (0.88 - 2.38) (47.1) (0.47 - 1.05) 
High Risk 1 5.00 3.67 3 35.00 5.89 1 1.18 2 1.45 3 1.11 
 (N=4*) (33.3) (3.46) (0.60 - 22.30) (75.0) (24.24) (2.41 - 14.41) (33.3) (0.51 - 2.72) (50.0) (0.51 - 4.12) (75.0) (0.61 - 2.02) 
 keep in mind that the distribution is skewed due to the large proportion of patients at 
“low risk” and the absence of a “high-risk” group. Nevertheless, the SBT-Neck is fairly 
able to distinguish between risk groups.29 
We utilised RRs to calculate the increased risk of the “medium-risk” and “high-risk” 
groups, compared to the “low-risk” group. All RR calculations using either the MCID 
of the NPRS, the NDI or the GPE were found to be statistically insignificant. The RRs 
with cut-off points based on the baseline median of the NPRS and the NDI offered 
better results; however, they did not represent the patients’ actual persisting pain or 
disability. The predictive validity was determined while the clinician applied ‘usual 
care’. In our cohort, no standardised therapy protocol was used as the clinician did 
not have access to the SBT score. In contrast to LBP, no stratified-care approach is 
available for patients with neck pain, and we expected the GP or PT to follow the 
guidelines when available.36,37 In other cases, clinicians were free to apply their 
therapy in the ways they deemed fit.  
 
Findings in the context of other literature 
This is the first publication on the SBT for patients with neck pain. One study 
published a version of the SBT that can be used for neck pain; however, it was 
specifically designed for multiple body regions.20 Also, no stratified care was applied 
to these patients. Other studies that make use of the SBT focus on LBP.9,12–19 The 
validation process of this study is comparable to that of the Dutch LBP version, which 
is also carried out within the PRINS study, and the results are largely comparable.  
For the construct validity, the scores are comparable with the LBP results except for 
question 3 (correlation with the NDI), where the correlation was lower than expected. 
This might be because we changed the answer option for questions 3 from the 
original version: in the original version, the answer option was “I have only walked 
short distances because of my back pain”, whereas in the modification, we altered 
the answer option to “I have used my arms and neck less due to my neck pain”, since 
the expert group considered this to be more relevant. However, this question is not 
covered by the NDI and possibly explaining the low correlation.  
For the reproducibility, we found that the quadratic kappa is slightly lower in this 
study—with .58 for neck pain, compared to .65 for LBP—and the specific agreement 
is slightly higher in neck pain.  
The initial SBT study that Hill et al. conducted, as well as all the translations, used an 
internal-consistency analysis and a psychosocial subscale, and calculated a 
discriminant validity using an area under the curve.9,12,13,38,39 In our study, we 
approached the tool as a formative model, making this calculation redundant. 
 
Strengths and limitations 
The strength of this study is that it is the first one to have successfully modified the 
SBT to a neck-pain version. Whilst the construct validity, reproducibility and content 
validity are all moderate to good, the predictive validity is insufficient when using 
 ‘usual care’ as treatment instead of a targeted treatment. The advised minimum 
sample size was met, except for the reproducibility (44 instead of 50), and our aim for 
a minimum of 100 persons was not met for the predictive validity.  
Another limitation of this study is that, for feasibility reasons, the baseline 
questionnaire was filled in after the first consultation instead of before. During the 
initial consultation, a patient’s cognition might be altered, which would influence the 
results. 
 
Clinical and/or research implications 
The SBT-Neck requires further research to determine whether current questions and 
cut-off points are optimal. Also whether stratified care could be added and would than 
lead to a faster recovery. 
 
CONCLUSION 
 
The SBT is modified to fit patients with neck pain in Dutch primary care. The 
predictive validity is insufficient on individual prognosis for the instrument to be used 
in the present form.  
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 Appendix 1; The Dutch version of the STarT Back Tool for patients with neck 
pain. 
 
	
	
The	STarT	Back	Screening	Tool:	Dutch	Neck	Version	
Auteur:		J.D.	Bier,	B.W.	Koes,	R.W.J.G.	Ostelo,	B.	Mutsaers,	N.	Wildervanck,	A.P.	Verhagen		(2014)	
	
Naam:	_______________________________		 	 Datum:	_____________		
Antwoord	u	alstublieft	ieder	onderdeel.	Kruis	bij	ieder	onderdeel	het	vakje	aan	dat	op	u	van	
toepassing	is.	Soms	is	het	moeilijk	om	tussen	twee	vakjes	te	kiezen,	kruis	dan	het	vakje	aan	dat	uw	
probleem	het	beste	beschrijft.	Kruis	niet	meer	dan	één	vakje	per	onderdeel	aan!		
Denk	bij	het	beantwoorden	van	de	volgende	vragen	telkens	aan	de	situatie	in	de	laatste	2	weken.		
	
	 Oneens	 Eens	
	 				0	 			1	
	 	
1. In	de	laatste	2	weken	straalde	mijn	nekpijn	wel	eens	uit	naar	één	of	beide		 				o	 											o	
armen.	
2. In	de	laatste	2	weken	heb	ik,	naast	mijn	nekpijn,	wel	eens	pijn	ergens			 				o	 											o	
anders	gehad.		
3. In	de	laatste	2	weken	bewoog	ik	mijn	nek	en/of	armen	minder	vanwege			 				o	 											o	
mijn	nekpijn	
4. In	de	laatste	2	weken	kleedde	ik	me	trager	dan	gewoonlijk	aan	vanwege			 				o	 											o	
mijn	nekpijn.	
5. Voor	iemand	in	mijn	toestand	is	het	echt	niet	veilig	om	lichamelijk	actief		 				o	 											o	
	te	zijn.	
6. Ongeruste	gedachten	gingen	vaak	door	mijn	hoofd.		 				o	 											o	
7. Ik	vind	dat	mijn	nekpijn	verschrikkelijk	is	en	ik	geloof	dat	het	nooit	meer			 				o	 											o	
beter	zal	worden.	
8. Over	het	geheel	genomen	heb	ik	niet	genoten	van	alle	dingen	waar	ik	vroeger							o	 											o	
wel	van	genoot.	
9. Over	het	geheel	genomen,	hoe	hinderlijk	was	uw	nekpijn	in	de	laatste	2	weken?	
	
In	het	geheel	niet	 Een	beetje	 Matig	 Erg	 Extreem	
	 o	 o	 o	 o	 o	
	 	0	 	0	 	0	 	1	 	1	
	
	
	
Totale	uitslag	(alle	9)	:	__________________									Sub	Uitslag	(Q5-9):______________	
	

 Appendix 2; The comparison between the original SBT, the Dutch neck pain 
version and its English translation. 
 
  Original SBT Dutch neck version English translation of the Dutch neck version 
1 My back pain has spread down my leg(s) at some time in the last 2 weeks 
In de laatste 2 weken straalde mijn nekpijn wel eens 
uit naar één of beide armen. 
In the past 2 weeks my neck pain sometimes radiated 
in one or both arms. 
2 I have had pain in the shoulder or neck at some time in the last 2 weeks 
In de laatste 2 weken heb ik, naast mijn nekpijn, wel 
eens pijn ergens anders gehad. 
In the past 2 weeks I had pain in other parts of my body 
next to my neck pain. 
3 I have only walked short distances because of my back pain 
In de laatste 2 weken bewoog ik mijn nek en/of 
armen minder vanwege mijn nekpijn. 
In the past 2 weeks I moved my neck and / or arm less 
because of my neck pain. 
4 In the last 2 weeks, I have dressed more slowly than usual because of back pain 
In de laatste 2 weken kleedde ik me trager dan 
gewoonlijk aan vanwege mijn nekpijn 
In the past 2 weeks I dressed more slowly than usual 
because of my neck 
5 It’s not really safe for a person with a condition like mine to be physically active 
Voor iemand in mijn toestand is het echt niet veilig 
om lichamelijk actief te zijn 
For someone in my condition it's really not safe to be 
physically active 
6 Worrying thoughts have been going through my mind a lot of the time Ongeruste gedachten gingen vaak door mijn hoofd.  Worrying thoughts often went through my head. 
7 I feel that my back pain is terrible and it’s never going to get any better 
Ik vind dat mijn nekpijn verschrikkelijk is en ik geloof 
dat het nooit meer beter zal worden 
I think my neck pain is terrible and I believe it will never 
get better 
8 In general I have not enjoyed all the things I used to enjoy 
Over het geheel genomen heb ik niet genoten van 
alle dingen waar ik vroeger wel van genoot Overall, I have not enjoyed all the things I used to enjoy 
9 Overall, how bothersome has your back pain been in the last 2 weeks? 
Over het geheel genomen, hoe hinderlijk was uw 
nekpijn in de laatste 2 weken? 
Overall, how bothersome was your neck pain in the 
past 2 weeks? 
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 ABSTRACT  
 
 
Objective: 
To evaluate whether current Dutch primary-care clinicians offer tailored treatment to 
patients with lower-back pain (LBP) or neck pain (NP) according to their risk 
stratification, based on the Keele STarT (Subgroup Targeted Treatment) Back-
Screening Tool (SBT). 
 
Design: 
Prospective cohort study with 3 month follow-up. 
 
Setting: 
Primary care. 
 
Participants: 
General practitioners (GPs) and physiotherapists included patients (N=284) with 
non-specific LBP, NP or both. 
 
Interventions: 
Patients completed a baseline questionnaire, including the Dutch SBT, for either LBP 
or NP. A follow-up measurement was conducted after 3 months to determine 
recovery (using Global Perceived Effect Scale), pain (using Numeric Pain Rating 
Scale), and function (using Roland Disability Questionnaire or Neck Disability Index). 
A questionnaire was sent to the GPs and physiotherapists to evaluate the provided 
treatment. 
 
Main outcome measures: 
Prevalence of patients’ risk profile and clinicians’ applied care, and the percentage of 
patients with persisting disability at follow-up. A distinction was made between 
patients receiving the recommended treatment and those receiving the non 
recommended advised treatment. 
 
Results: 
In total, 12 GPs and 33 physiotherapists included patients. After 3 months, we 
analyzed 184 patients with LBP and 100 patients with NP. In the LBP group, 52.2% 
of the patients were at low risk for persisting disability, 38.0% were at medium risk, 
and 9.8% were at high risk. Overall, 24.5% of the patients with LBP received a low-
risk treatment approach, 73.5% a medium-risk, and 2.0% a high-risk treatment 
approach. The specific agreement between the risk profile and the received 
treatment for patients with LBP was poor for the low-risk and high-risk patients 
(21.1% and 10.0%, respectively), and fair for medium-risk patients (51.4%). In the 
 NP group, 58.0% of the patients were at low risk for persisting disability, 37.0% were 
at medium risk, and 5.0% were at high risk. Only 6.1% of the patients with NP 
received the low-risk treatment approach. The medium-risk treatment approach was 
offered the most (90.8%), and the high-risk approach was applied in only 3.1% of the 
patients. The specific agreement between the risk profile and received treatment for 
patients with NP was poor for low-risk and medium-risk patients (6.3% and 48.0%, 
respectively); agreement for high-risk patients could not be calculated. 
 
Conclusion: 
Current Dutch primary care for patients with nonspecific LBP, NP, or both does not 
correspond to the recommended stratified-care approach based on the SBT, as most 
patients receive medium-risk treatment. Most low-risk patients are overtreated, and 
most high-risk patients are undertreated. Although the stratified-care approach has 
not yet been validated in Dutch primary care, these results indicate there may be 
substantial room for improvement.  
 INTRODUCTION 
 
Low back pain (LBP) and neck pain (NP) are major public health problems; they are 
the primary and fourth causes, respectively, of disability worldwide.1 With regard to 
health-seeking behavior for LBP and NP, approximately 55% of patients seek 
healthcare, and between 12% and 32% visit a general practitioner (GP).2–4 
Nonspecific LBP and NP are the main focus of most primary-care guidelines.5,6 The 
guidelines from both the Dutch General Practitioners Society and the Royal Dutch 
Physiotherapists Society divide patients with nonspecific LBP and NP into roughly 
two subgroups: (1) normal recovery, which is defined as a decrease in pain and 
function limitation prior to consultation; and (2) a (suspected) delayed recovery.5,7,8  
The Keele STarT (Subgroup Targeted Treatment) Back-Screening Tool (SBT) is a 
tool, developed in England, to allocate primary-care patients with LBP to 3 prognostic 
subgroups: patients at either low, medium or high risk for persisting disability.9 This 
allocation aims to ensure that the appropriate stratified care is applied to patients at 
risk for persistent LBP in order to prevent it.10 This tool’s questions are based on 
known negative-prognostic factors that can be influenced by treatment. Furthermore, 
the SBT has been found to be a valid and reliable tool for subgrouping patients in the 
United Kingdom9, and it has been translated and validated in several languages, 
including Dutch11, since its initial English publication in 2008.12–18 The Dutch version 
of the SBT has been modified to fit patients with NP.19 The SBT, and corresponding 
targeted treatment, has yet to be implemented in the Netherlands. 
Recommended care for normal recovery is to reassure the patient and inform him or 
her of the positive prognosis, and to advise the patient to stay active, which might be 
supported with the prescription of pain medication. If the pain persists or worsens, 
the GP can refer physiotherapy to the patient. Where current guidelines advise a 
stepped approach for patients with a delayed recovery, the SBT advises a stratified-
care approach; the difference between these 2 approaches relates to the timing of 
(effective) interventions. Implementing the SBT in the United Kingdom has led to 
higher quality-adjusted life years for patients and lower health costs, and superior 
outcomes in the high-risk group using stratified care.20,21 No studies have been 
published on stratified care for patients with NP; however, we expect that it will not 
differ from the approach for LBP. Before advising on implementing the SBT in the 
Netherlands, we need more insight into the current usual care because 
implementation of the SBT might be unnecessary if usual care provides comparable 
or better outcomes. Therefore, the aim of this study is to evaluate current Dutch 
primary care for spinal pain and whether it corresponds to the advised stratified-care 
approach based on the SBT. 
 
 
 
 METHOD 
 
Design 
The prevalence of risk groups in neck- and back-pain patients according to the SBT 
(PRINS) study is a prospective cohort study, which includes patients with LBP or NP 
of any duration that consulted a GP or physiotherapist. The study was approved by 
the medical ethics committee of the Erasmus University, Rotterdam, the Netherlands 
(METC-2014-256). 
 
Participants 
Care providers 
We asked GPs and physiotherapists, who work in the primary-care sector and had 
displayed interest in the SBT during pilot projects, to participate in the PRINS study. 
Information about the study protocol was provided through several meetings, by 
phone or by digital/paper documentation, and participating GPs and physiotherapists 
received the study protocol and a folder with patient information and informed 
consent forms. The majority of these GPs and physiotherapists work in small clinics 
in the region of Rotterdam (a maximum of 50 kilometers).  
Patients 
The inclusion period for patients started in November 2014 and continued through to 
May 2015, and patients consulting their GP or physiotherapist for LBP or NP during 
that period were invited to participate. Other inclusion criteria were that the patient 
had to be 18 years old or over, could speak and read Dutch and had an email 
address.  
Patients were excluded if, during the consultation, the GP or physiotherapist found 
“red flags” indicating a possible serious underlying pathology (eg. infection, fracture, 
cauda equine, tumor) responsible for the LBP or NP.  
Patients were provided with oral and written information about the aim of the study 
and the procedure of data collection, and each patient signed an informed consent, 
which was handed back to the GP or physiotherapist who subsequently registered 
the patient online. The patient immediately received an e-mail with a link to the 
baseline questionnaire, and if necessary, a reminder to complete the questionnaire 
was sent after a few days. Patients who did not complete the baseline questionnaire 
within 7 days were excluded from the cohort. 
 
Treatment 
The patients received usual care from their GPs or physiotherapists, who were kept 
blind for the results of the patients’ baseline questionnaire.  
 
Baseline measurements  
The baseline questionnaire consisted of questions on demographic data, the SBT 
(either the back or neck version) and the Numeric Pain Rating Scale (NPRS)22 to 
 assess pain; the Neck Disability Index (NDI)23 or the Roland Disability Questionnaire 
(RDQ)24,25 to assess disability; the Tampa scale26 for kinesiophobia; and the pain-
catastrophizing scale27 and the EQ-5D (European Quality of Life-5 Dimensions) 28 to 
assess quality of life. The NPRS options range from 0 (no pain) to 10 (worst 
imaginable pain), the RDQ consists of 24 statements with a “yes” or “no” answer 
option and a total score ranging from 0 to 24, and the NDI consists of 10 statements 
with a 6-point scale ranging from 0 (not limited) to 6 (completely limited) and a total 
score ranging from 0 to 50. 
 
Outcome measure 
Three months after inclusion, the patients received a follow-up questionnaire to 
assess pain (Numeric Pain Rating Scale), disability (RDQ or NDI) and recovery, 
using the Global Perceived Effect Scale. The answer options on the GPE range from 
1 (fully recovered) to 7 (worse than ever). 
Persisting LBP disability was defined as an RDQ score ≥ 7, based on the mean of 
the baseline score as used by Hill at al.9, while persisting NP disability was defined 
as an NDI score ≥ 13, based on the median baseline score in this cohort.  
Three months after inclusion, the GP was sent a questionnaire to inquire about the 
number of visits, prescribed medication, referrals to physiotherapists or medical 
professionals and requested imaging and blood tests. The physiotherapist received a 
questionnaire to inquire about treatment data such as the number and period of 
treatments, and the aim and means of treatment. The investigator sent and received 
all questionnaires digitally, and they were handled and stored through LimeSurvey 
2.05. 
 
Analysis 
Treatment categorization  
The 2 authors utilized the following criteria to independently categorize the 
treatments applied by the GPs and/or physiotherapists (in case of differences 
between the authors, the categories were determined by consensus):  
• Low-risk approach – the GP provided information, advice and some 
analgesics or 1 or 2 physiotherapy consultations, and the treatment was 
hands-off and consisted of offering information, advice and exercises. 
• Medium-risk approach – in addition to the low-risk approach, the GP 
referred the patient to a physiotherapis , and the physiotherapist performed an 
evidence-based intervention. 
• High-risk approach – in addition to the medium-risk approach, the GP 
referred the patient to either a physiotherapist specialized in treating patients 
with a psychosomatic approach, a psychologist or equivalent, and the 
physiotherapist assessed bio-psychosocial risk factors and used cognitive 
behavioral principles as interventions.29  
 
 Statistical analysis 
We described the characteristics of the clinicians and patient population using 
frequencies (means with SDs). Next, we calculated the frequencies of patients per 
SBT risk profile and the clinicians’ treatment approaches. The specific agreement 
calculates percentages of recommended treatment approaches for each risk profile 
separately.30 For example, patients who were “low-risk” at baseline and treated as 
such are calculated as a proportion of patients that were “low-risk” on either of the 2 
measurements. We modified the specific agreement to fit a 3x3 table, as illustrated 
in Table I, because the original method is done in a 2x2 table. We rated a specific 
agreement < 40% as poor, 40% to 59% as fair, 60% to 74% as good and 75% to 
100% as excellent. Lastly, we calculated the percentage of patients with persisting 
disability per risk profile; this was done for the groups receiving the recommended 
and non-recommended treatments.  
 
Table I; specific agreement 
    Follow-Up (T1) 
Baseline (T0) Risk Low  Medium High 
  Low (A) (B) (C) 
  Medium (D) (E) (F) 
  High (G) (H) (I) 
NOTE. Low-risk, A/(A+(B+C+D+G)/2); Medium-risk, E/(E+(B+H+D+F)/2); High-risk, 
I/(I+(C+F+G+H)/2). 
 
RESULTS 
 
Study population 
The GPs and physiotherapists originally included 370 patients; however, 86 patients 
failed to fill in the baseline questionnaire and were excluded. The characteristics of 
the 284 remaining patients are presented in Table II. The 12 GPs included 103 
patients (26 with NP and 77 with LBP) and the 33 physiotherapists included 181 
patients (74 with NP and 107 with LBP). The 4 groups (NP/LBP stratified for GP/ 
physiotherapist) are largely comparable in gender, age, fear of movement, pain 
catastrophizing and pain intensity, and the percentages of SBT-risk profiles of each 
of the 4 groups are also comparable: the low-risk profile percentage ranges from 
50.0% to 60.8%, the medium-risk profile percentage ranges from 35.1% to 42.3% 
and the high-risk profile percentage ranges from 4.1% to 11.2%. General 
practitioners tend to see a higher proportion of chronic patients with LBP compared 
to physiotherapists (68.8% vs. 48.6%).  
 
 
 
 
 Follow-up 
The follow-up questionnaire for GPs and physiotherapists had a non-response of 
3.9% (n = 11), and the follow-up questionnaire for patients had a failure to follow-up 
of 14.4% (n = 41). Thirteen patients were seen by both a GP and a physiotherapist; 
in this analysis, these patients are analyzed in both groups. Figure I (patient flow) 
displays all patients analyzed despite patients’ failure to follow-up. 
Due to the clinicians’ non-response, the specific-agreement analysis was performed 
on 273 patients (175 with LBP and 98 with NP), and due to the patients’ non-
response, the persisting disability analysis was performed on 243 patients (150 with 
LBP and 93 with NP). Due to both the clinicians’ and patients’ non-response, the 
treatment analysis was performed on 234 patients (142 with LBP and 92 with NP). 
 
Figure I; Patient flow 
 
 
Treatments 
The 2 authors independently categorized the treatments that the physiotherapists 
applied, and, in 90.5% of the cases, agreed on their categorization. The 
categorization of the GPs’ treatments was performed in SPSS (version 24). The 
authors decided that the treatment offered by a GP, whereby he performed 
manipulations himself, is categorized as medium-risk (comparable to referring the 
patient to a physiotherapist, irrespective of the number of manipulations).  
Lower back pain 
In the specific-agreement analysis, the majority of the patients with LBP were at low 
risk for persisting disability (n = 95; 54.3%). Thirteen (13.7%) of these patients 
received the SBT-recommended low-risk treatment approach, which resulted in a 
specific agreement of 22.4% (Table III). According to the SBT, all other patients (n = 
82) were over-treated. Receiving the treatment approach for medium or high risk did 
not result in a lower percentage of persisting disability (Table IV). 
We found that of the 64 (36.8%) patients who were considered to be at medium risk, 
 55 (85.9%) received treatment corresponding to this risk profile (specific agreement 
= 51.4%), 7 patients received a low-risk treatment (undertreated) and 2 a high-risk 
treatment (over-treated). Both over- and undertreated patients had a higher 
percentage of persisting disability compared to the group that was treated in 
accordance with its risk profile. 
In the group of patients that were considered to be at high risk for persisting disability 
(n = 16; 9.2%), only 1 patient (6.3%) received the high-risk treatment approach 
(specific agreement = 10.0%). According to the SBT, all other patients (n = 15) were 
undertreated. We found that these undertreated patients had an average of 6.5 
physiotherapy sessions, and the patients treated as high risk received 8.5 
physiotherapy sessions on average.  
 
Table II; baseline characteristics 
    Total GP PT 
Characteristics   Neck   (n=100) 
Back 
(n=184) 
Neck 
(n=26) 
Back       
(n=75) 
Neck     
(n=74) 
Back    
(n=108) 
Woman 65 (65.0%) 103 (56.0) 17 (65.4) 42 (54.5) 48 (64.9) 61 (57.0) 
Age in years, mean (SD) 45.6 (14.3) 44.7 (14.6) 45.4 (12.5) 40.7 (14.7) 45.7 (14.9) 47.5 (13.9) 
SBT§ risk profile             
  Low 58 (58.0) 96 (52.2) 13 (50.0) 42 (54.5) 45 (60.8) 54 (50.5) 
  Medium 37 (37.0) 70 (38.0) 11 (42.3) 29 (37.7) 26 (35.1) 41 (38.3) 
  High 5 (5.0) 18 (9.8) 2 (7.7) 6 (7.8) 3 (4.1) 12 (11.2) 
SBT score, mean (SD) 3.4 (1.8) 3.6 (2.0) 3.7 (2.0) 3.4 (2.0) 3.3 (1.8) 3.7 (2.1) 
Episode duration             
  <1 mo 27 (27.0) 53 (28.8) 7 (26.9) 15 (19.5) 20 (27.0) 38 (35.5) 
  1 to 3 mo 18 (18.0) 26 (14.1) 5 (19.2) 9 (11.7) 13 (17.6) 17 (15.9) 
  >3 mo 55 (55.0) 105 (57.1) 14 (53.8) 53 (70.7) 41 (55.4) 52 (69.3) 
Pain intensity|, mean ± SD 5.5 (1.9) 5.9 (1.8) 5.4 (1.9) 5.7 (1.9) 5.6 (1.9) 6.0 (1.8) 
  Mild (0-5) 41 (41.0) 63 (34.2) 14 (53.8) 27 (35.1) 27 (36.5) 36 (33.6) 
  Moderate (5-7) 46 (46.0) 88 (47.8) 8 (30.8) 38 (49.4) 28 (51.4) 50 (46.7) 
  Severe (8-10) 13 (13.0) 33 (17.9) 4 (15.4) 12 (15.6) 9 (12.2) 21 (19.6) 
Disability (NDI)¶, mean (SD) 14.1 (6.8) NA 14.2 (8.8) NA 14.1 (6.1) NA 
Disability (RDQ)#, mean (SD) NA 9.5 (5.9) NA 8.9 (5.7) NA 10.0 (6.1) 
Fear (TSK)*, mean (SD) 32.2 (5.9) 34.8 (7.1) 33.8 (5.6) 35.2 (6.3) 31.7 (5.9) 34.4 (7.6) 
Catastrophising (PCS)†, mean (SD) 12.7 (10.0) 13.8 (10.3) 16.5 (12.4) 14.6 (11.2) 11.4 (8.7) 13.1 (9.6) 
Referral   NA NA NA NA 17 (23.6) 23 (23.2) 
NOTE. Values are numbers (percentage) unless otherwise indicated.  
§  SBT = STarT Back Tool (total score range 0-9) 
| Pain intensity is measured on a Numeric Pain Rating Scale (0-10) 
¶  NDI = Neck Disability Index (0-50) 
#  RDQ = Roland Disability Questionnaire (0-24) 
* TSK = Tampa Scale of Kinesiophobia (17-63) 
† PCS = Pain Catastrophizing Scale (0-65) 
 
 
 
 
 
 Table III; Specific agreement analysis between baseline risk profile and 
treatment as provided 
  Treatment profile   
Baseline  Low Medium High Specific Agreement (%) 
LBP (n=175)         
Low-risk 13 81 1 22.4 
Medium-risk 7 55 2 51.4 
High-risk 1 14 1 10.0 
          
NP (n=98)       
Low-risk 2 55 0 6.3 
Medium-risk 3 30 3 48.0 
High-risk 1 4 0 NA 
NOTE. Values are n or as otherwise indicated. Analysis based on patients’ baseline-
data and clinicians treatment-data. Specific agreement is interpreted as the 
proportion of patients that had that specific risk profile on either baseline or in the 
treatment profile. 
Table IV; treatment analysis for low back pain* 
        Persisting 
Disability, n (%) Baseline Treatment N (%) 
LBP (n=142)       
  Low-risk Low 9 (12.0) 2 (22.2) 
  Medium 65 (86.7) 13 (20.0) 
  High 1 (1.3) 1 (100.0) 
  Medium-risk Low 6 (11.3) 3 (50.0) 
  Medium 45 (84.9) 15 (33.3) 
  High 2 (3.8) 2 (100.0) 
  High-risk Low 0 (0.0) 0 (NA) 
  Medium 13 (92.9) 7 (53.8) 
  High 1 (7.1) 1 (100.0) 
  Under treated 19 (13.4) 10 (52.6) 
  Rightfully treated 55 (38.7) 18 (32.7) 
  Over treated 68 (47.9) 16 (23.5) 
NOTE. Analysis based on patients’ baseline-data and follow-up data, and clinicians 
treatment-data. ‘Persisting Disability’ is the amount and percentage of patients with 
persisting disability in the corresponding treatment group. Abbreviation: NA, not 
applicable 
 
  
 Neck pain 
In the specific-agreement analysis, 57 (58.2%) of the 98 patients with NP were 
considered to be at low risk for persisting disability. Two of these patients (3.5%) 
received the corresponding low-risk treatment approach (specific agreement = 
6.3%); other patients were considered to be over-treated (Table III) and had a higher 
percentage of persisting disability at 3 months (Table V). 
We found that while 36 patients (36.7%) were considered to be at medium risk for 
persisting disability, only 30 patients (83.3%) received care that corresponded to 
their medium-risk profile (specific agreement = 48.0%); the remaining 6 patients 
were equally divided between receiving the low- and high-risk treatment approach. 
Of the 98 patients with NP, the smallest group contains the patients considered to be 
at high risk for persisting disability (N = 5; 5.1%). None of these patients received the 
high-risk treatment approach, making it impossible to calculate the specific 
agreement. On average, these patients underwent 7.2 physiotherapist sessions, 
while patients treated as high risk in this study received 8.8 sessions on average. 
 
Table V; treatment analysis for low neck pain* 
        Persisting 
Disability, n (%) Baseline Treatment N (%) 
NP (n=92)       
  Low-risk Low 2 (3.7) 0 (0.0) 
  Medium 52 (96.3) 7 (13.5) 
  High 0 (0.0) 9 (N/A) 
  Medium-
risk 
Low 3 (8.8) 0(0.0) 
  Medium 28 (82.4) 10 (35.7) 
  High 3 (8.8) 3 (100.0) 
  High-risk Low 1 (25.0) 1 (100.0) 
  Medium 3 (75.0) 2 (66.7) 
  High 0 (0.0) 0 (N/A) 
  Under treated 7 (7.6) 3 (42.9) 
  Rightfully treated 30 (32.6) 10 (33.3) 
  Over treated 55 (59.8) 19 (34.5) 
NOTE. Analysis based on patients’ baseline-data and follow-up data, and clinicians 
treatment-data. ‘Persisting Disability’ is the amount and percentage of patients with 
persisting disability in the corresponding treatment group. Abbreviation: NA, not 
applicable 
 
Physiotherapy treatments 
In the specific-agreement analysis, we found that 86.2% of the patients with LBP and 
90.8% of the patients with NP received a medium-risk treatment approach, which 
suggests a one-size-fits-all approach in current usual care. Only 7 patients (3.0%) 
received a high-risk approach, over half of the patients were over-treated (47.9% for 
 LBP and 59.8% for NP), and between 32.6% (NP) and 38.7% (LBP) received the 
targeted treatment. The LBP and NP patients that were given the correct treatment 
had almost the same percentage of persisting disability in 3 months (32.7% for LBP 
and 34.5% for NP).  
 
General practitioners referral 
The GPs referred 10 patients (9.9%) for imaging: 7 to rule out serious pathology and 
3 at the request of the patient. Three other patients were referred to a neurologist or 
an orthopedic surgeon due to persisting complaints; 1 of these referrals was at the 
request of the patient. In 27 cases, the GPs prescribed analgesic drugs; for 15 
patients (55.5%) this was time-contingent (compared to pain-contingent). 
Furthermore, we found an (almost) absence of a psychosocial approach or related 
referrals by the GP (eg. the high-risk approach). 
 
DISCUSSION 
 
Main findings  
GPs and physiotherapists treat the majority of their patients as medium-risk patients 
even though this majority is actually at low risk for persisting complaints. No large 
differences are found between NP or LBP patients. The minority of patients (36.7%) 
received care that corresponds to the recommended care according to the SBT 
approach; 52.2% of the patients were considered over-treated and 11.0% were 
undertreated.  
 
Interpretation  
The SBT approach advises 1 consultation with information or education for low-risk 
patients. We considered an intervention to match the low-risk profile if the GP or 
physiotherapist gave information or education in either 1 or 2 consultations. The GP 
also had the option to offer additional analgesics to the patient within the low-risk 
treatment approach. The United Kingdom healthcare system recommended an 
average of 4 interventions. In our cohort (LBP and NP combined), we found an 
average of 6.8 physiotherapy sessions and 8.7 sessions in the patients with a high-
risk profile. Furthermore, we found an (almost) absence of a psychosocial approach 
or related referrals (for example, the high-risk approach). This study clearly 
demonstrates that clinicians tend to treat the majority of their patients as medium-risk 
patients; they do not stratify and treat patients based on the perceived risk of 
persistent complaints, and over half of the patients are over-treated. In low-risk 
patients with LBP, we see that the majority of the patients recover, irrespective of a 
low or medium-risk intervention. We expect the same for NP; however, due to the 
small proportion of patients receiving a low-risk approach, we could not evaluate this. 
Also, no conclusions can be drawn from the high-risk population due to the small 
sample size.  
 One Irish study conducted a non-randomized clinical trial in 332 LBP patients who 
were included in a historical cohort.21 This group received a generic 12-week group 
education or exercise program, comparable to the medium-risk approach, while an 
intervention group of 251 LBP patients received a stratified-care approach. Stratified 
care demonstrated a superior effect on the high-risk group; however, the study did 
not analyze the usual care, as was done in this study. 
In the original SBT study, stratified care was the intervention that was compared to a 
usual-care approach and found that the intervention group displayed a higher mean 
change in disability compared to the control group; however, no information about 
the specific contents of usual care was provided.20 No other studies have been found 
that analyze unprotocolled usual care in contrast to the SBT approach. 
Other remarkable findings are that the GPs referred 10 patients for imaging even 
though they were labeled as nonspecific LBP or NP, meaning that there were no 
signs or signals indicating serious pathology. The GP guidelines advise against 
diagnostic imaging in these instances31,32, since imagery may lead to higher 
healthcare costs due to additional tests and treatment, but may not improve clinical 
outcomes and may even lower the quality of life.33,34 While analgesics were 
prescribed to 44.5% of the patients on a pain-contingent basis, the GP guidelines 
advise doing so on a time-contingent basis.31 
 
Strengths and limitations 
This is the first study that compares current usual care with the advised stratified-
SBT approach in the Netherlands, and provides insight into the question regarding 
whether specific implementation of stratified care is required or whether usual care 
already properly categorizes patients.  
Our results have limited generalizability for the group of high-risk patients because 
this group was quite small. At the moment, the SBT approach is only available for 
LBP patients, and so far, no study has been conducted on an SBT approach for 
patients with NP; however, the conditions are rather comparable. Our categorization 
of usual care was based on the information that physiotherapists provided. They 
wrote their (primary) treatment goals and means, and we may have missed certain 
psychosocial factors that were addressed but not reported in the patient files. 
 
In the United Kingdom, the SBT has the potential to predict persisting disability in 
clinical practice. We found differences between usual care and the recommended 
stratified care, since most patients received the therapy recommended for medium-
risk patients. Educating clinicians on the SBT approach, especially for the low and 
high-risk groups, is necessary for this approach to be effective in reducing pain, 
function and sick leave in the Netherlands. However, prior to making efforts to 
change the working method, it is essential to determine what causes clinicians to 
treat patients as they do. A qualitative study should be undertaken to gain insight. 
  
 CONCLUSION 
 
Current Dutch usual care does not correspond to the recommended stratified-care 
approach based on the SBT for patients with nonspecific LBP or NP. Clinicians tend 
to treat the majority of their patients as medium-risk patients even though most of 
them were found to be low-risk patients. 
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 ABSTRACT 
 
The Royal Dutch Society for Physiotherapy (KNGF) issued a clinical practice 
guideline for physical therapists that assess and treat patients with non-specific neck 
pain including cervical radiculopathy in Dutch primary care. Recommendations are 
based on a review of published systematic reviews.  
During the intake the patient is screened for serious pathologies and analysing the 
corresponding patterns. Patients with a cervical radiculopathy can be in- or excluded 
through corresponding signs and symptoms and possibly diagnostic tests (Spurling, 
traction/distraction, and Upper Limb Tension Test). History taking is done to gather 
information about patients’ limitations, course of pain, and prognostic factors such as 
coping style and health related questions.  
In case of a normal recovery (profile A) management should be hands-off and 
patients should receive advice from the Physiotherapist (PT) and possibly some 
simple exercises to supplement ‘acting as usual’.  
In case of a delayed/deviant recovery (profile B) the PT is advised to use, in addition 
to profile A, forms of mobilization and/or manipulation in combination with exercise 
therapy. Other interventions may be considered in addition. The PT is recommended 
not to use dry needling, low-level laser, electrotherapy, ultrasound, traction and/or a 
cervical collar. 
In case of a delayed/deviant recovery with clear and/or dominant psychosocial 
prognostic factors (profile C) these should first be addressed by the PT where 
possible or referred to a specialist where necessary.  
In case of neck pain grade III (profile D) the therapy resembles profile B but the use 
of the cervical collar may be considered in for pain reduction. The advice is to use it 
sparsely: only for a short period per day and only for a few weeks. 
  
 BACKGROUND  
In 2012 the global burden of disease study stated that neck pain is globally the 4the 
largest physical complaint regarding years lived with disability.1 The estimated one-
year incidence of neck pain has been reported to vary between 10.4 to 21.3%.2 Data 
from 2003, in the Dutch population aged 25 years and over, showed that the neck is 
the third most common musculoskeletal complaint, after the lower back and the 
shoulder region.3 The total costs of spinal pain in the Netherlands in 2011 were 1.3 
billion euros (1.5% of the total healthcare costs and 0.2% of the gross domestic 
product): 40% of these costs are thought to be related to neck pain and 29% of the 
total costs are related to primary care of which physiotherapy is a part.4 
 
Definition of Neck pain and Scope of the Guideline  
Neck pain is described as ‘an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage’ in the neck region which starts at 
the superior nuchal line and down to the level of the scapular spine.5 This includes 
Whiplash Associated Disorder (WAD), cervicogenic headache, and cervical radicular 
syndrome. Neck pain has been classified by the Neck pain Task Force (NPTF) four 
grades, see table I.6  
 
Table I; Neck Pain Task Force classification 
Grade I Neck pain and associated disorders with no signs or symptoms 
suggestive of major structural pathology and no or minor interference with 
activities of daily living.  
Grade II No signs or symptoms of major structural pathology, but major 
interference with activities of daily living. 
Grade III No signs or symptoms of major structural pathology, but presence of 
neurologic signs such as decreased deep tendon reflexes, weakness, or 
sensory deficits. 
Grade IV Signs or symptoms of major structural pathology. Major structural 
pathologies include (but are not limited to) fracture, vertebral dislocation, 
injury to the spinal cord, infection, neoplasm, or systemic disease 
including the inflammatory arthropathies. 
 
The Neck pain guideline covers neck pain grades I to III. Grade I and II include two 
specific subgroups: trauma-related neck pain (previously known as whiplash or 
WAD) and work-related neck pain, based on patient’ statement on the cause or 
onset of pain.7,8 
 
Clinical Course and Prognosis 
In a general population 50 to 85% of the patients with neck pain will report neck pain 
1 to 5 years later.9 A Dutch cohort study of patients with neck pain in primary care 
found that after one year 76% of the patients stated to be fully recovered or much 
 improved, although 47% reported still to have (some) neck pain.10 In patients with 
acute neck pain the pain and disability decrease in the first six weeks with about 
45%, but no further decrease can be found afterwards.11 Neck pain in the working 
population seems to be quite persistent and takes a recurrent course.12 60 to 80% of 
workers with neck pain will report neck pain one year later.12 In the trauma related 
neck pain subgroup improvement in pain and disability mainly occurs within the first 
three months following the accident.13 A systematic review found recovery rates 
range from 16% to 99%.14 Roughly 50% of people with neck pain continue to 
experience some degree of neck pain 6 to 12 months following an accident.15,16 
Prognosis is important in the process of clinical decision-making. When the 
prognosis of a patient is favorable the intervention may be limited to education and 
advice, while a patient with a poor prognosis might need an in-depth evaluation 
followed by a specific therapy or intervention.13  
 
Prognostic Factors 
Knowledge about the prognosis and the prognostic factors is essential for 
determining an indication for physiotherapy and/or an intervention strategy. When 
the current course of neck pain is favorable and there are no (or a limited amount of) 
negative prognostic factors there is no indication for physiotherapy besides giving 
information and advice. When the current course is delayed and the physiotherapist 
(PT) can influence the negative prognostic factors, there might be an indication for 
physiotherapy. Despite the multiple research and reviews there are a number of 
predictors that provide low or very low confidence or inconclusive results.13 A large 
survey suggests a gap between current best-evidence and actual practice in 
establishing a prognosis in neck pain.17 Factors frequently found to be prognostic for 
persisting neck pain are, amongst others, history of other musculoskeletal disorders, 
passive coping style, and psychosocial distress.9,12,13,15,17–19  
The Royal Dutch Society for Physiotherapy (KNGF) issued and funded a guideline 
for PT and manual therapists who treat patients with non-specific neck pain and 
related health complaints in Dutch primary care.20,21 It aims to (1) increase uniformity 
and quality of physiotherapy health care, (2) define the boundaries and the domain of 
the PT in relation to patients with neck pain, (3) ensure that patients receive the 
optimal care and (4) support the PT in making decisions in the choice of diagnostic 
and therapeutic interventions. 
 
METHOD 
 
The guideline committee was formed in September 2013. The guideline committee 
consisted of neck-pain experts, PT’s and epidemiologists. Members were chosen for 
their expertise on the subject and their experience in previously published guideline 
development committees. The first author was responsible for collecting the data and 
drafting the guideline. The other authors were responsible for verifying the 
 statements made in the clinical practice guideline (CPG). The CPG was developed 
according to the method used for physiotherapy guidelines issued by the 
KNGF.20 The method consists of five different phases: (1) preparation, (2) 
development, (3) validation, (4) implementation (5) evaluation and update. This 
article focuses on phase one to three. The AGREE II instrument has been used to 
assist development.22 
We searched for studies on prognosis of neck pain, accuracy of diagnostic tests, and 
effectiveness of therapeutic interventions within the domain of physiotherapy and 
manual therapy.21,23–25 These interventions have all been described by the KNGF 
and are (in alphabetical order): cognitive behavioral treatment, cervical collar, dry 
needling, education, electrotherapy, exercise, joint mobilization, kinesiotape, low 
level laser therapy, manipulation, massage, neurodynamics, pillow, thermal agents, 
traction, shockwave, and workplace interventions.25 
Best evidence was sought from recent systematic reviews, randomized controlled 
trials (RCTs) and prospective observational studies.20 We used recent documents 
from the Neck Pain Task Force (NPTF)6–9,12,15,26–35, the International consensus on 
Neck (ICON)13,16–18,36, recently published guidelines such as the guideline from the 
Canadian Chiropractic Association and the American Physiotherapy Association.37,38 
and Cochrane reviews.39–50 Additional relevant articles were searched through 
Pubmed searches using MESH-headings or free text words in combination with the 
central search term ‘neck’ or ‘cervical’.  
 
Critical Appraisal Process 
The authors appraised all included articles for its quality. Articles were assessed 
using generally accepted and appropriate tools; e.g. QUADAS for diagnostic tests, 
PEDro for randomized controlled trials. All intervention studies were assessed as 
having high, unclear or low risk of bias and subsequently appraised for quality using 
the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE)-system.51 The levels of evidence are presented in table II.51 Evidence 
based on randomized controlled trials begins as high quality evidence, but the 
confidence in the evidence may be decreased for several reasons, including:  
• Study limitations (studies were suffering from high risk of bias) 
• Inconsistency of results (studies showed clinical or statistical heterogeneity) 
• Indirectness of evidence (the study population differed from the target 
population of the guideline) 
• Imprecision (too few studies or included patients; e.g. less than 300 patients 
or events) 
• Reporting bias, publication bias or a fatal flaw.  
 
 
 
 
 Table II; Quality of evidence and definitions 
Level of 
quality Definition 
High Further research is very unlikely to change our confidence in the estimate of effect 
Moderate Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate 
Low 
Further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the 
estimate 
Very low Any estimate of effect is very uncertain 
 
Once evidence was graded, the evidence was translated into recommendations for 
clinicians. When clinical experience of the guideline committee had a role in the 
recommendations this is explicitly stated. Cost-effectiveness did not influence the 
recommendations and none of the guideline committee members had any conflict of 
interest besides partially working in the primary care. The recommendations were 
formulated reflecting the evidence into strong recommendations using terms as “is 
recommended” (evidence indicates that the intervention is effective) or “is not 
recommended” (evidence indicated that the intervention is not effective). In case of 
weak or unclear evidence recommendations are formulated as “may be 
considered”.52 Where possible these recommendations are stated separately for 
patients with trauma-related neck pain, work-related neck pain or neck pain grade III. 
 
External review by stakeholders 
After finalizing the first draft the board of directors of the KNGF gave feedback on the 
guideline. This did not result in any changes in the recommendations in the 
guideline.  
The guideline then underwent a review form external stakeholders. These 
organizations were: The Dutch Patients and Clients Federation (NPCF), The Dutch 
Association of Manual Therapists (NVMT), Dutch General Practitioners Association 
(NHG), The Dutch Society for Psychosomatic Physiotherapy (NFP), Dutch 
Association for Occupational Physical Therapists (NVBF), Dutch Association of 
Orthopedic Surgeons (NOV), Dutch Association of Rehabilitation Physicians (VRA), 
Dutch Association of Anesthesiology (NVA) and the Association of Dutch Healthcare 
Insurers (ZN). 
Next, the KNGF issued a work field analysis, which was performed under 93 PT to 
review their opinion of the guideline and its feasibility through a written feedback 
form. A second method was used to measure 20 PT’s provided care though 
performance indicators before and after attending a presentation about the guideline. 
A focus-group meeting with the latter group was to evaluate the results and 
experiences. Revisions were made to the document based on the feedback.  
 The comments from the work field analysis and an update of the search resulted in 
the final guideline. The guideline and the supporting documents have been published 
in Dutch on www.fysionet-evidencebased.nl and are accessible for members and 
non-members of the KNGF. 
 
RESULTS  
 
Summary of the content of the clinical practice guideline 
In the Netherlands a patient with neck pain can be referred to a PT by a general 
practitioner or medical specialist. It is also possible that the patient can consult a PT 
without referral; this is called direct access to PT services. The guideline was 
constructed according to the different phases of the physiotherapy assessment: 
intake, physical examination, analysis, treatment, and evaluation of treatment.  
 
Intake 
During the first consultation the patient will undergo a ‘screening procedure’ to 
assess whether physiotherapy treatment is indicated. The PT first evaluates 
complaints and symptoms and checks for any red flags. Red flags are patterns of 
signs or symptoms (warning signs) that may indicate serious pathology, requiring 
further medical diagnostics. When red flags (table III) are present it might be an 
indication for a specific pathology (e.g. Neck Pain Grade IV).  
 
The PT analyses, within the clinical reasoning process, whether the red flags are 
consistent with the patient’s complaints based on age, gender, incidence and 
prevalence, information on onset of complaints, signs and symptoms. If present and 
not explicable by a known pattern of neck pain the patient has to be referred to or 
returned to their general practitioner.56 The evidence supporting the red flags for 
neck pain is weak and inconsistent since many red flags are rather generic (such as 
unexplained weight loss) and suffer from high false positive rates.29,43,57 When no red 
flags are present, the diagnostic process continues with an intake. Dutch PTs cannot 
refer patients for diagnostic imaging, this is reserved for general practitioners or 
medical specialists. The use of diagnostic imaging to rule-in or rule-out a specific 
serious pathology (Grade IV) has a low to moderate reliability.34 A remarkable 
situation in diagnostic imaging is the relatively high proportion of positive findings in 
healthy people.58,59  
The initial aim in the diagnostic process is to identify the patient’s problems by 
formulating initial hypothesis/hypotheses about the diagnosis and further refining this 
hypothesis (clinical reasoning).60 During history taking the PT is able to gather 
information about the patients’ deficits in body structure and functions, the patients’ 
limitations in daily activity and restriction in participation. Also it is important to gather 
information about the patient’s environmental and personal factors that can lead to 
chronicity. It is known that certain psychosocial factors can negatively influence the 
 neck pain. In this diagnostic process the PT helps the patient to structure treatment 
goals and health management strategies based on clinical data, patient’s 
preferences, and professional knowledge and judgment.61 The PT tries to objectify 
the information from the intake where necessary, with measurement instruments if 
available. The PT is recommended to use the Numeric Pain Rating Scale 
(NPRS)62,63 to objectify pain and the Patient-Specific Functional Scale (PSFS)62,64 to 
objectify limitations in activity.  
During the intake it is important to identify a possible Grade III neck pain because the 
approach and policy are different from neck pain Grade I and II. A possible Grade III 
neck pain will be accompanied by certain signs and symptoms in addition to neck 
pain65: sensory symptoms in the arm such as paraesthesia, numbness, sensory 
changes, a cervical range of motion described as limited and painful and motor 
disturbances such as upper limb weakness and/or muscle atrophy. 
 
Table III; Red flags per possible serious pathology 
Possible pathology Corresponding red flags 
Fracture Older age53, History of trauma34,53, corticosteroid use, 
osteoporosis.34 
 
Vertebralis dissection 
 
Cerebrovascular symptoms or signs54 
 
Injury to the spinal 
cord or cervical 
myelopathy 
 
Neurological symptoms e.g. widespread neurological signs in 
both arms or in the leg(s) such as sensory deficits or loss of 
muscle strength in the limbs, and bowel and bladder 
dysfunction.34 
 
Infection (including 
urinary tract infection 
or skin infection) 
 
Symptoms and signs of infection (e.g. fever, night sweats), 
risk factors for infection (e.g. underlying disease process, 
immunosuppression, penetrating wound, intravenous drug 
abuse, exposure to infectious diseases).34 
 
Neoplasm 
 
Past history of malignancy, failure to improve with a month of 
treatment, unexplained weight loss,34,38 age >50yr, 
dysphagia, headache, vomiting.34 
 
Systemic disease 
(Herpes Zoster, 
Ankylosing 
spondylitis, 
inflammatory arthritis, 
rheumatic arthritis) 
 
Headache, fever, unilateral skin rash, burning pain, inching.55 
 
 Physical examination 
Differentiating between neck pain grades I/II and grade III can be done during 
physical examination where specific provocation or reduction tests can be used. 
Research showed that the following tests are the most valid: the Upper Limb Tension 
Test A (ULTT) for the nervus medianus, the Spurlings' test, in the combination of 
side bending and extension of the cervical spine, and the traction/distraction test.66 A 
negative ULTT is found valid as a high sensitive test (sensitivity range 0.72 – 0.97, 
specificity range 0.11 - 0.33) to rule patients out, meaning these patients probably do 
not have a cervical radiculopathy.66,67 The Spurlings’ test (sensitivity range 0.90 – 
1.00, specificity range 0.94-1.00) and the traction/distraction test (sensitivity 0.44, 
specificity range 0,90 – 0,97) are regarded valid as a specific test to rule in, meaning 
the patient probably has a cervical radiculopathy.66–68 
Other clinical tests are not recommended in the physical examination of the neck as 
they vary and are not very standardized. That is why their accuracy is quite variable 
and overall insufficient.34 This does not mean that it should not take place. In the 
clinical reasoning process, the physical examination aims to further refine the 
diagnostic hypothesis based on the findings from the intake e.g. to rule-in or rule-out 
a certain hypothesis. Furthermore it also aims to objectify the level of physical 
functional limitations and to assess secondary factors that could negatively influence 
the recovery process. Common forms of physical examination are inspection in rest, 
inspection during movement, and assessing physical functions such as joint function, 
muscle control and movement patterns. When evaluating the validity of physical 
examination or provocation tests the reliability of the procedure is also an issue. 
Studies evaluating the reliability of physical examination of the neck often find low to 
moderate reliability (Kappa 42-82%).69,70 
 
Analysis 
When during the intake the PT finds no reason to suspect a neck pain grade IV the 
PT will have to differentiate between neck pain Grade I, II or III. If during the intake 
the presence of neurological signs such as numbness, paraesthesia, muscle 
weakness are found and in addition of the physical examination the patient is likely 
to suffer from neck pain grade III, radiculopathy. In this case the PT is recommended 
to consult the patient’s general practitioner to report the findings and discuss the 
treatment options. 
The PT uses the information from history taking to analyse the pain severity, 
limitations in activities and restriction in participation. Based on the data collected, 
the patients’ health problem can be analysed. When the PT assumes that the patient 
will suffer from a delayed recovery, he or she should check for any factors that might 
explain the persistent nature of the neck pain episode. The PT will assess if the 
prognostic factors, found during history taking, can be influenced and/or if the 
therapy can be given according to the guideline. The use of questionnaires to 
objectify psychosocial prognostic factors may be considerd.71–74 
 Based on the history taking and the findings of the physical examination, the PT 
assigns the patient to a profile: The guideline committee recommends the use of the 
following patient profiles. Profile A; Neck Pain Grade I/II-normal course. Profile B; 
Neck Pain Grade I/II, delayed course without dominant psychosocial influence. 
Profile C; Neck Pain Grade I/II, delayed course with dominant psychosocial 
influence. Profile D; Neck Pain Grade III. 
 
Treatment 
For treatment profile A the PT will inform the patient about the expected course of 
pain and provide some take home exercises. It is recommended that the PT limits 
the treatment to three sessions.  
For treatment profile B the PTs’ goal is to guide the patient to a quick return to 
normal daily activities and the prevention of chronicity. The following treatments 
have, on average, a moderate level of evidence showing a positive effect in contrast 
to a placebo or other treatments, and are therefore recommended to be used: 
mobilization75, manipulation75–77 and exercise therapy78. The recommended 
intervention is a combination of these.79 There is very low quality evidence that 
information and education for patients with neck pain is effective but in the opinion of 
the working group it is an essential part of the therapy.18,50  
The following treatments may be considered by PTs in treating patients with neck 
pain preferably in addition to the advised treatment. These treatments have a low or 
very low level of evidence. The evidence shows small effects in contrast to other 
treatments or placebo: cognitive behavioural treatment / graded activity80, cervical 
collar for patients with neck pain grade III18,50, massage45, neurodynamics or neural 
tissue management41, pillow18, (kinesio) tape81–83, thermal agents36, and workplace 
interventions84. The studies reporting on these treatments are either of low quality, 
show small effect sizes or show conflicting evidence. 
The following treatments have a low or very low level of evidence. They show no 
effects in contrast to other treatments or placebo. These treatments are 
recommended not to be used by PTs in treating patients with neck pain: dry 
needling85–87, low-level laser36,88,89, electrotherapy36,48,90, ultrasound36,42,90, traction47 
and cervical collar for neck pain grade I and II18,50. Studies on these interventions did 
not show any additional benefit when compared to a placebo or another intervention. 
For treatment profile C the therapy will correspond with profile B. The difference is 
the dominant psychosocial influence (psychosocial prognostic factors). These factors 
should be addressed prior to (or simultaneously with) applying other interventions as 
these factors are regarded as being ‘responsible’ for the delayed course of the neck 
pain. It may considered to be addressed by the PT where possible or referred to a 
specialist where necessary. 
For treatment profile D the therapy resembles profile B but differs on the use of the 
cervical collar that may be considered in this patient population for pain reduction but 
only when used sparsely; for a short period per day for a few weeks. 
 Evaluation of treatment 
The treatment is ended as soon as the agreed treatment goals have been achieved. 
Even if the goals have not been achieved, the treatment will have to be concluded at 
some stage. For instance, it is not useful to continue the treatment if no progress has 
been made after six weeks, as the chances of achieving progress after this period 
are small. This must be discussed explicitly with the patient before the final treatment 
session including whether the patient will be referred (back) to the general 
practitioner or not. 
The course of the treatment must be evaluated during the treatment, and at the final 
session. Besides evaluating the patient’s goals it is recommended to use the 
following measurement instruments at intake: the NPRS for pain and the PSFS for 
patient specific complaints, also the other instruments used during the intake 
provided these are suitable for evaluation. Both NPRS and PSFS have a minimal 
clinical important change of two points. This cut-off point is used to measure patients’ 
improvement.62,91 
 
DISCUSSION 
 
Limitations of the Guideline 
The CPG is primarily based on systematic reviews performed by the Cochrane, the 
ICON and NPTF. A choice made due to limitations in time and funds. Other 
stakeholders, including patients, were invited after the first concept was finalized. To 
strengthen the support it would be better to include these stakeholders in an earlier 
stage. This guideline reserved a group, profile C, for patients where recovery was 
delayed based on psychosocial factors. No evidence was available for this choice 
and no evidence is available that addressing these psychosocial factors will lead to 
recovery from neck pain. The same can be said for addressing other prognostic 
factors. 
The guideline is issued to fit the Dutch physiotherapy practice. This means that only 
the interventions are included that are within the professional domain of the Dutch 
PT, as defined by the KNGF. The validation process is also only done in the 
Netherlands. Both may influence the international generalizability of the guideline.  
Similarities and differences with international guidelines 
A recently updated CPG on Neck pain issued by the orthopedic section of the APTA 
shows great similarities concerning treatment advice, but differs on the subgrouping 
of patients.92 Where we use the Grade I-IV as advised by the NPTF the APTA 
guideline uses the international classification of disease and related health problems 
(ICD). The prognostic factors can be found in both guidelines where the APTA-CPG 
advises on more tools to appraise these constructs. Also there is more emphasis on 
clinical prediction rules where the Dutch PT CPG does not address these at all, as 
they are not regarded valid enough to be advised. Both guidelines address the same 
treatments; manual therapy, exercise, multimodal, education and physical agents 
 (dry needling, laser, ultrasound, TENS (transcutaneous electrical nerve stimulation). 
The Dutch PT CPG gives less direction to the form of manipulation, exercise or other 
modalities and when to use which form. Differences in treatment recommendations is 
that dry needling and laser are not recommended in the Dutch CPG. 
The Ontario Protocol for Traffic Injury Management (OPTIMa) published a guideline 
in 2016.93 This guideline focuses on the same grades of neck pain but limits the 
duration of neck pain to 6 months. In the recommendations of treatments OPTIMa 
makes a distinction between 0-3 months and 3-6 months. The Dutch guideline does 
not make that distinction. The OPTIMa guideline also advises on the use of non-
steroidal anti-inflammatory drug, electro acupuncture, and botulin toxin injections. 
These treatments are not regarded as PT-treatments in the Netherlands. Two 
differences in recommended treatments are that in the OPTIMa laser is a treatment 
for consideration and the Dutch guideline advises against its use. Also the use of a 
cervical collar may be considered in the Dutch guideline, in contrast to in the 
OPTIMa guideline. 
This clinical practice guideline is available in full text (in Dutch) on www.fysionet-
evidencebased.nl/ 
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General Discussion 
 
  
 GENERAL DISCUSSION 
 
The aim of this thesis is to provide insight into the prognosis and optimal care for 
patients with spinal pain in primary care – general practitioners (GPs) and physical 
therapists (PTs). In the previous chapters, we reported the results of all studies 
conducted. In this general discussion, we will present our main findings and discuss 
their interpretations. We will discuss the limitations and provide an overview of the 
literature with their similarities and contradictions. Finally, we will present 
recommendations for clinical practice and further research.  
 
KEY FINDINGS 
 
Chapter 2 
• When a GP offers guideline recommended care over a 4-week treatment 
period to patients with acute low back pain (LBP) in Australia, the majority 
(70%) of patients do not adhere to this advice, more specifically to the study 
medication.  
• Non-adherence is positively associated with higher baseline disability and 
negatively associated with a higher perceived risk that symptoms will be 
persistent, and with participants not claiming worker’s compensation. 
• Worsening of the complaint in the first week after consulting the GP is strongly 
associated with using additional healthcare or medication. 
Chapter 3 
• The Keele STarT (Subgroup Targeted Treatment) Back-Screening Tool (SBT) 
is successfully translated into Dutch, and it is regarded as a valid and reliable 
screening tool for patients with LBP in Dutch primary care 
Chapter 4 
• The SBT is modified to fit patients with neck pain in Dutch primary care. 
• The validity of the SBT for neck pain (in the present form) is not yet sufficient 
for use in clinical practice. 
Chapter 5 
• The majority of patients who consult primary care in the Netherlands are 
regarded as being at low risk for persisting complaints. 
• Clinicians treat the majority of their patients as medium-risk patients even 
though they are regarded as being at low risk or high risk for persisting 
complaints.  
• Fifty-two percent of the patients with LBP or neck pain are considered to be 
over-treated according to the SBT approach. 
Chapter 6 
• A clinical-practice guideline (CPG) is provided for Dutch PTs to assist in their 
diagnostic and therapeutic processes in patients with neck pain. 
 • The advised physical therapy treatment for patients with neck pain at grades I 
and II with a normal recovery is to offer information and advice. A wait-and-
see policy is likely to be sufficient. 
• The advised physical therapy treatment for patients with neck pain at grades I 
and II with a deviant recovery is a combination of mobilisation (or 
manipulations) with exercise therapy. 
• The advised physical therapy treatment for patients with a grade III neck pain 
is a combination of mobilisation (or manipulations) with exercise therapy. The 
short-term use of a soft collar may be considered. If pain increases or therapy 
is ineffective, then the patient should be referred to his or her GP. 
 
DISCUSSION OF THE MAIN FINDINGS 
Usual care 
In our study (chapter 5), usual care for patients with neck pain and/or LBP is 
described and compared to the SBT approach (targeted treatment). The researchers 
did not inform the clinicians about the patients’ risk profile; these clinicians were 
completely free to apply care as they saw fit. We expected the clinicians to provide 
guideline-recommended care or, in the absence of a guideline, evidence-based 
interventions. Knowledge on the difference between the advised stratified care and 
the usual care is essential before both deciding on the implementation of the SBT 
and developing an implementation plan.  
We found that the majority of the patients (55%) were at low risk for persisting LBP, 
but the majority of these patients (88%) received a moderate-risk approach. It seems 
that a one-size-fits-all approach is applied. In our study, we also found that low-risk 
patients (in the case of LBP as well as neck pain) received 6.5 physical therapy 
sessions, medium-risk patients 6.7 and high-risk patients 8.5 sessions. The overall 
mean for patients with neck pain or LBP was 6.8 sessions, while the mean for 
musculoskeletal conditions in the Netherlands in 2015, according to the Dutch 
institute for health-services’ research (NIVEL), was 7.8 with a median of 6.1 To a 
large extent, these numbers correspond to each other; however, they differ from the 
results found in the UK.  An implementation study from the UK found that, in 201 
patients treated by 29 PTs, a mean of 2.7 National Health Service (NHS) physical 
therapy sessions were given after implementation of the SBT.2 The implementation 
of the  “improve patient care through targeted treatment (IMPaCT) back” study 
reported an average of 3.8 sessions prior to implementation, and 4.2 sessions after 
implementation of the SBT.3 Both studies report a substantially lower number of 
sessions in the UK in comparison to the Dutch findings, implying large differences in 
approaches and possibly also due to differences in healthcare system between the 
two countries. The differences between the amounts of sessions also suggest there 
is room for more efficiency in the approach of low back pain and possibly also in 
neck pain. 
 Another remarkable finding in our study is the overall absence of a psychosocial 
approach. No differences are found between the approaches on LBP and neck pain. 
Recovery from these two forms of spinal pain are both known to being influenced by 
psychosocial factors, as discussed in chapter 6, the CPG on neck pain, but also in 
other CPG.4–6 The knowledge that these modifiable factors may lead to persisting 
spinal pain is the reason that Hill et al., included them in the SBT.7 In this study, 
usual care was described based on reports in the patient file. It might be that the 
clinician addressed the psychosocial factors but did not report on this, or just simply 
did not address these factors during consultation. If the latter is the case, then this 
requires thorough training, especially when implementing the SBT. Alternatively, or 
additionally, referral between colleagues should be facilitated. In the Netherlands 
there are PTs with an additional degree in a psychosomatic approach. These 
psychosomatic physical therapists could well fill the need for therapists willing to 
implement the SBT but are not additionally trained to address the patients with the 
high-risk of persisting pain. 
The main purpose of the SBT is to fast-track patients to the appropriate care. In this 
study, we found that, on the one hand, current care tends to overtreat patients (low-
risk patients), and on the other hand, it demonstrates that Dutch clinicians only 
sparsely apply a psychosomatic approach in treating patients with spinal pain (high-
risk patients). Of course, we still need to study whether the stratified approach leads 
to better and quicker recovery, and whether this also leads to lower costs. However, 
this study does indicate that we do need a tool to better serve our patients instead of 
using a one-size-fits-all approach. There is clearly room for improvement. I would 
argue that the improvement can be found in the SBT by allocating patients to the 
appropriate treatment; however, the tool would work better if the system does not 
facilitate overtreatment by means of a financial incentive for the PT where they get 
paid more when they deliver more treatments. 
 
Keele SBT 
The SBT is a nine-item questionnaire aiming to stratify patients into one of three risk 
profiles (low, medium, or high-risk), and it is part of a stratified-care model for 
managing LBP. The SBT has been translated into several different languages since 
its initial publication in 2008.8–20 Overall, the validation process demonstrated great 
similarities. The initial validation study of the SBT in the UK, along with later studies, 
preformed a factor analysis to confirm two constructs. Other studies did not perform 
a factor analysis but used the known subgroups to perform an internal consistency 
analysis by means of the Cronbachs alpha. 7,12,13,15,19,21 We did not preform a factor 
analysis or calculate the internal consistency. The main argument for this is that we 
expect the internal consistency to be neither high nor low because we expect all 
questions or factors to independently influence the outcome. Also, we did not 
calculate the specificity and sensitivity of the instrument. Calculating these would 
mean that we had to combine two groups to be able to compare them (low versus 
 medium/high or low/medium versus high). We chose to calculate the relative risk 
(RR) to determine the persisting disability. The RR is, in our opinion, more relevant 
for clinicians when using the instrument, and it offers us the ability to analyse each 
group separately. 
In calculating the predictive validity for the SBT for LBP, we used the outcome 
measure “persisting disability”, which was defined as a Roland Morris disability 
questionnaire score (RDQ) of ≥ 7 at 3 months. This cut-off score between yes/no 
persisting disability was arbitrarily chosen as the median of the baseline scores in 
the initial SBT study.7 In validating the SBT for neck pain, we used the same method 
of defining persisting disability as a neck disability index (NDI) score equal to or 
higher than the median of the NDI on the baseline. We also analysed patients at a 
more individual level where we used the RR of patients’ recoveries defined as an 
NDI score that decreased more than the minimal clinically important difference 
(MCID) of 4 points. The latter method seems most appropriate because it detects the 
improvement of disability and not a patient’s disability level compared to the group’s 
mean level.  
For the SBT for neck pain, the predictive validity could be regarded as good when 
looking at the population level, using the median of the baseline score. However, the 
predictive validity is insufficient at an individual level, using the MCID. Choosing the 
analysis method can determine whether the tool is regarded as suitable or not. 
The overall score and the psychosocial subscale of questions, as determined by Hill 
et al., determines a patient’s risk profile. When the overall score is ≤ 3, the risk profile 
results in a low risk for persisting disability; an overall score > 4 and the subscale 
score (questions 5-9) lead to medium and high risk categorisations. In all 
international validation studies, we found that these cut-off points were the same as 
the original study. Only in one of the Danish validation studies did the author report 
on changing the cut-off points to examine their influence on the odds ratios.22 The 
preliminary results of a secondary analysis on the PRINS (Prevalence of RIsk groups 
in Neck- and back pain patients according to the STarT back screening tool) data 
demonstrates that changing the cut-off points influences the distribution in risk 
profiles, resulting in a higher percentage of high-risk patients and an improvement in 
the RR. (Article under preparation) 
A Danish study on the SBT found that episode duration influenced the outcome, and 
that the SBT was less reliable in patients in the first two weeks of their back pain.17 In 
our study of patients with LBP, 21% had these complaints for two weeks or less, and 
19% of the patients with neck pain had these complaints for two weeks or less. 
Besides the episode duration at the baseline, the moment of applying the SBT may 
influence the results. In the original SBT study, the questionnaire was administered 
prior to the first consultation, and in our study, the SBT was administered after the 
first consultation. In the UK study, the percentage of patients in the high-risk profile is 
15, whereas in our study, it was 10%. The preliminary results from the PRINS-II 
study confirm this difference. The SBT in this study is administered prior to the first 
 consultation, resulting in a shift towards a higher risk profile. One explanation might 
be that during the first consultation, a patient’s beliefs about his illness, cognitions, 
medical knowledge, and coping style may already have been influenced or altered. 
When the psychosocial factors are addressed or even altered within the first 
consultation, these factors might be irrelevant to the patient being at risk for 
persisting disability, and therefore he or she might not be a true high-risk patient. 
Appling the SBT after the first consultation may lead to a practical obstacle when a 
patient is at low risk for persisting disability and, according the stratified-care model, 
only in need of one consultation. Therefore, I would advise using the SBT prior to or 
during the first consultation mainly for practical reasons as it gives the PT the option 
to let the SBT determine or influence the treatment plan. 
Initially, the SBT was developed to cater for patients with non-specific LBP; however, 
the SBT has also been validated for patients with a lumbar central canal stenosis.19 
The SBT has been modified to fit patients with other musculoskeletal conditions, 
including neck, upper limb, lower limb or multisite pain.23–26 In our studies, we 
included patients with LBP, neck pain, or both. In a previous study, where we used 
the SBT for both LBP and neck pain, we noticed that patients had trouble prioritising 
their complaints, and were not able to distinguish between LBP and neck pain when 
they had both. We interpreted the combined SBT to be invalid, since we did not know 
whether the patient was answering the questionnaire for their neck pain or their back 
pain. We could also have made the choice not to distinguish between the two and 
interpret these as multi-site pain instead. Our aim was to develop a neck-pain 
version rather than a multi-site version; therefore, we separated the SBT. We kept 
the original version for LBP and modified it to fit patients with neck pain. 
In developing the neck-pain version, our starting point was that we wanted to stay as 
close as possible to the LBP version and only replace items that were specific to 
LBP. Based on the outcome of a single focus-group meeting, we changed the 
wording of questions that stated “low-back pain” to “neck pain”. Question 1 “radiating 
pain in the legs” was modified to “radiating pain in the arms”. Question 3 was 
changed to “I have used my arms and neck less due to my neck pain” instead of “I 
have only walked short distances because of my back pain”. The previously 
mentioned modified SBT (for back, neck, upper limb, lower limb or multisite pain) had 
a different approach to altering the questions. It based the replacement items on the 
available proxy items from the data set that it was tested on.26  
We chose our method because we wanted to stay as close to the original SBT as 
possible. In doing so, we did not perform an analysis to look for factors related to 
persisting neck pain; therefore, we could have included unrelated factors in the 
modified SBT. The SBT for neck pain would benefit from a more thorough approach 
in analysing factors related to persisting neck pain. As the data-set is now available, 
further analysis of this data, in looking for replacement items, might lead to a more 
valid instrument.  
 
 Clinical practice guideline 
The Royal Dutch Society for Physical Therapy (KNGF) issued the development of a 
CPG on neck pain in 2013. The aim of the CPG is to assist PTs when assessing and 
treating patients with non-specific neck pain, including cervical radiculopathy in 
Dutch primary care. It is the first guideline on neck pain as a whole in the 
Netherlands. Previous guidelines focused on a specific neck pain, for example, 
whiplash-associated disorders (WAD) or disorders such as complaints on arm, neck 
and shoulder (CANS). 
The CPG on neck pain demonstrates great similarities to the CPG on LBP when it 
comes to the classification of patients. Both these guidelines primarily explore the 
current course of pain and/or disability. It determines whether the course is normal or 
deviant, and, when the course is deviant, it focuses on the presence of psychosocial 
factors that influence this deviant course. In treating patients with spinal pain, we find 
similarities to the approach of the SBT and the CPG. The CPG’s normal course of 
pain or disability corresponds to the SBT’s low-risk profile. In both subgroups, the 
focus is on information and advice. The deviant course in the CPG corresponds to 
the SBT’s medium-risk profile; in both subgroups, the advised approach is an 
evidence-based physiotherapeutic intervention. The deviant course of pain or 
disability with psychosocial factors demonstrates similarities to the SBT’s high-risk 
profile in which it is advised that a patient receives a psychosomatic approach from a 
PT who is skilled in this field. Apart from these similarities, there is an essential 
difference between the CPG and the SBT: the moment at which the intervention is 
applied. The SBT stratifies patients at the baseline without the need to analyse the 
course of pain and disability, making the SBT an instrument to fast-track the patient 
to the appropriate care. However, it must be noted that one Danish study found that 
the SBT for LBP might not have the ability to stratify patients in the acute phase. If 
the clinician has to wait two weeks before applying the SBT, then he is also able to 
analyse the course of pain or disability. However, this is mainly applicable to low-risk 
analysis. In analysing the difference between medium- and high-risk profiles, the 
SBT might be a useful supplement to the Dutch CPG to determine whether a 
psychosocial approach is indicated – an area in which the current guideline offers 
little or no direction.  
While the CPG demonstrates similarities to the LBP’s CPG in its classification, it 
differs from other guidelines in its methods of recommendations. During the first 
guideline committee meeting, we chose to include all interventions within the domain 
of the PT. This includes interventions for which there is little to no evidence or 
interventions that seem illogical when used in the cervical region. These 17 
interventions were consensus-based by the KNGF.27 Data was collected and 
assessed using the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) system.28 The recommendations were formulated, reflecting the 
evidence, into strong recommendations using terms such as “is recommended” 
when the evidence indicated that the intervention is effective, or “is not 
 recommended” when the evidence indicated that the intervention is not effective. In 
cases of weak or unclear evidence, recommendations are formulated as “may be 
considered”.29 The majority of interventions are in the category of “may be 
considered”. We also have interventions that were “not recommended”, since we 
chose to include all interventions. To our knowledge, this is the second guideline (out 
of the 17 CPGs currently available) that advises against certain interventions.  
The recommendations against electrotherapy, low-level laser therapy, and 
ultrasound (including shockwave) therapy were accepted by the PTs without 
comments or remarks. Recommendations against dry needling were met with some 
resistance due to personally assumed or experienced effects.  
The list of 17 interventions included relatively new interventions, such as the 
previously mentioned dry needling and shockwave therapies. These interventions 
are gaining popularity amongst Dutch PTs without clear evidence of efficacy. In the 
absence of evidence, the guideline cannot recommend the use of these 
interventions. We know that, on average, clinicians’ adherence to guidelines is quite 
low.30–32 Advising against popular interventions with personally assumed effects may 
lead to a lower adherence. We must keep in mind that it is expected that more 
evidence will arise regarding relatively new interventions. This evidence must be 
incorporated in the guideline on a regular base. The guideline must be a dynamic 
document that is frequently subjected to (small) updates, with the users of the 
guidelines – the clinicians – being informed. 
 
Patients’ adherence 
There is an extensive body of literature focusing on the adherence of GPs to the 
guidelines for treating LBP. Depending on the focus of the study, we found that up to 
50% of GPs do not adhere to the guidelines.30–32 These results are comparable to 
PTs where adherence is as low as 7% to 50%.33,34 Non-adherence often leads to 
increased diagnostic workups, such as the use of X-rays, CT scans, and MRIs. The 
use of these techniques is discouraged in the guidelines as they often offer no 
diagnostic benefit and may be associated with a lower quality of life.31,35 The 
‘unnecessary’ diagnostic interventions are also reported in chapter 5 where we 
describe usual care in the Netherlands. We found that 10% of the patients (with non-
specific neck pain or non-specific LBP) who consulted their GP were referred to a 
medical specialist, and in 45% of the patients, GPs prescribed the pain medication 
on a pain-contingent basis rather than on the advised time-contingent basis. When 
the clinicians were asked why patients got referred to a medical specialist or went for 
an X-ray, we found that, in half of the cases, this was at the request of the patient. 
Chapter 2, which focuses on patients’ adherence to guideline recommended care, 
concluded that 70% of the patients did not adhere to the guideline recommendations. 
Combining both clinicians’ and patients’ non-adherence would result in an even 
lower percentage of overall guideline adherence. Therefore, studies focusing on 
either patients’ or clinicians’ non-adherence lead to a one-sided view.  
 In the PACE-trial (paracetamol for low back pain) analysis, the majority of patients’ 
non-adherence was due to not taking the medication as prescribed. These patients 
were asked to take a maximum dose of study medication; therefore, non-adherence 
was defined as taking less than 70% of the recommended dose. The 70% threshold 
allowed room for the patient to forget to take his or her medication a few times 
without regarding him or her as non-adherent. The study protocol requested that 
patients continue taking the pain medication until they were pain-free for seven 
consecutive days.36 This seems quite long and does not correspond to pain 
guidelines or LBP guidelines.5,6,35 I would argue that this seven-day period would 
also contribute to the non-adherence. 
 
IMPLICATIONS AND RECOMMENDATIONS 
 
Recommendations and research 
The SBT has been validated for LBP; however, the risk ratios are determined on an 
arbitrarily chosen cut-off point of an RDQ ≥ 7. Since the SBT aims to offer a targeted 
treatment, it would be a better fit to determine the cut-off point on patients’ individual 
levels. For example, in the SBT for neck pain, we used an improvement of less than 
the MCID or worsening to define “persisting disability”. This method of calculating the 
risk ratios could also be applied to the SBT for LBP. Another analysis that could be 
performed to improve the SBT in the Netherlands is to determine the ideal cut-off 
points for distinguishing between low, medium, and high risk and for improving the 
risk ratios. When these analyses are done, we need to determine whether the SBT 
with targeted treatment would lead to better and quicker recovery at lower costs. In 
the UK, this analysis has been performed; however, results cannot be extrapolated 
to the Netherlands, mainly due to the large difference in healthcare systems between 
the two countries. A Dutch replication study of the RCT performed in the UK would 
seem fit.  
For the SBT neck, we performed a study to determine whether it had the potential to 
perform as well as the original SBT. It does have the potential; however, the tool 
needs further development and testing. We could analyse whether the prognostic 
validity improves when certain questions are replaced. In the dataset gathered in the 
PRINS-study, we have the results of the NDI, the Tampa Scale for Kinesiophobia 
(TSK), the Pain Catastrophising Scale (PCS) and the quality of life questionnaire 
(EQ-5D). This dataset can be used in a secondary analysis. Also, an analysis, as 
suggested for the SBT for LBP, could be performed to change cut-off points to 
improve predictive validity. 
In regards to the guideline adherence it is known to be low, both by clinicians and 
patients. The actual non-adherence is a result of both clinician and patient non-
adherence. I would suggest that CPG non-adherence is studied in combination, with 
the aims of gathering not only quantitative data on the amount of non-adherence and 
the analysis of factors known to contribute to this non-adherence, but also qualitative 
 data of clinicians and patients to determine the reason of why non-adherence took 
place. 
 
Recommendations for clinical practice  
STarT Back Tool 
Usual care in the Netherlands is a time-based, stepped-care approach that is based 
on the available CPG (for LBP), a related CPG (WAD/CANS/pain management) or 
own clinical experience.4,5,37,38 The SBT is ready to be used in the Netherlands in 
patients with LBP to assist clinicians in making decisions regarding treatment. In the 
Netherlands, we need to determine how to apply stratified care. One of the steps is 
to improve the quality of the information given to patients. The information that a PT 
gives a patient should contain the same core message that the GP offers and that 
the patient finds online or in information brochures. In the UK, this information is 
provided in the form of a booklet – ‘the back book’ – and a supplementary film. In the 
Netherlands, a paper information booklet, an e-book, a website and a 10-minute film 
are developed for patients with LBP as part of a second cohort for the SBT (PRINS-
II). The information is based on interviews with patients and clinicians to determine 
the core messages. The same products are developed for patients with neck pain as 
part of the implementation of the CPG. Because high-quality information, uniformly 
delivered by clinicians, is essential. In this stage the information is used, when 
applying the CPG on neck pain, and hopefully in a later stage when using the SBT 
for neck pain. In the Netherlands, all information products are available to clinicians 
and patients with LBP or neck pain. 
Clinicians in England have the option to receive training to apply stratified care. This 
training is available for all risk profiles; however, the most training is needed 
regarding the high-risk approach, and is described as psychologically informed 
interventions.7 Whether Dutch PTs require additional training must be determined, 
since there are differences between English and Dutch PTs. In the Netherlands I 
would recommend that patients who need a high-risk approach for their LBP should 
be referred to a psychosomatic PT. This is also advised in the CPG for neck pain 
when psychosocial factors are limiting recovery. 
 
Clinical practice guideline 
The CPG has been issued by the KNGF. In addition to writing the CPG, the authors 
were asked to provide lectures on this topic; however, they were not involved in the 
implementation of the guideline. Furthermore, they were only sparsely updated on 
the actions undertaken by the KNGF regarding the implementation. In the 
Netherlands, the KNGF not only serves and represent Dutch PTs and issues the 
guidelines, but also facilitates trainings for PTs. When these trainings match the 
guideline, this would benefit implementation. Currently, strange contradictions exist 
regarding the KNGF policy: on the one hand, the KNGF publishes a guideline that 
advises against the use of dry needling in patients with neck pain, and on the other 
 hand, it facilitates and promotes dry needling training for neck pain. The KNGF 
should develop an implementation plan in collaboration with the authors. It should 
also focus on delivering the core message to the users of the CPG and avoid 
presenting mixed messages. The CPG is an easy-to-use document that should be 
adopted by all Dutch PTs. 
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 Summary 
  
 SUMMARY  
 
Chapter 2 describes the magnitude of patient reported nonadherence with guideline-
recommended care for acute low back pain. The data from 1643 participants enrolled 
in the PACE trial evaluating the effectiveness of paracetamol for acute low back pain 
was used for the analysis. 
Patient received guideline recommended care; reassurance, simple analgesia, and 
the advice to stay active and avoid bed rest. The analgesia consisted of a time-
contigent paracetamol, a paracetamol as required dosing of paracetamol, or placebo. 
Also advice against additional treatments and referral for imaging was given. 
Patients completed questionnaires and a medication diary. Nonadherence was 
defined as (1) failure to consume the advised paracetamol dose, or (2) receipt of 
additional healthcare, tests, or medication during the trial treatment period (4 weeks). 
Multivariable logistic regression analysis was preformed to determine the factors 
associated with nonadherence.  
In the first week of treatment, 39.7% of the participants were classified as 
nonadherent. Over the 4-week treatment period 70.0% were nonadherent, 57.5% did 
not consume the advised paracetamol dose. Higher perceived risk of persistent pain, 
lower level of disability and not claiming workers’ compensation were independently 
associated with nonadherence with odds ratios ranging from .46 to 1.05. We 
concluded that the adherence to guideline-recommended care for acute low back 
pain was poor. Most participants do not take the advised paracetamol dose.  
 
Chapter 3 describes the translation of the Keele STarT (Subgroup Targeted 
Treatment) Back-Screening Tool (SBT) into Dutch. Next it describes the reliability 
and validity of the SBT in Dutch primary care setting among 184 patients with non-
specific low back pain. 
The SBT was formally translated in Dutch following a multistep approach for forward 
and backward translation. General practitioners and physiotherapists included 
patients with low back pain, which completed a baseline questionnaire and follow-up 
questionnaires at three days and three months. Of the 184 patients 52.2% were 
categorized in the low-risk subgroup, 38.0% medium-risk and 9.8% in the high-risk 
subgroup. For the construct validity we found a moderate to high Pearson’s 
correlation for question 3 to 9 and a low correlation for question 1 and 2 with their 
respective reference questionnaires. The reproducibility had a quadratic weighted 
kappa of 0.65 and the specific agreement of 82.4% for low-risk, 53.3% for medium-
risk and 33.3% for high-risk. For the predictive validity for persisting disability we 
found a relative risk ratio for medium-risk of 1.8 (95% CI 1.0 – 3.1) and 2.7 (95% CI. 
1.4 – 4.9) for high-risk compared to low-risk. For the content validity we found that no 
floor and ceiling effects were present. We concluded that the SBT is successfully 
translated in Dutch. Furthermore, the psychometric analysis showed acceptable 
 results and therefore we regard it as a valid screening tool for patients with low back 
pain in Dutch primary care 
 
Chapter 4 evaluates the reliability and validity of the Dutch version of the SBT for 
patients with neck pain. General practitioners and physiotherapists included 100 
patients who completed both a baseline and a follow-up questionnaire at 3 days and 
3 months.  
Out of 100 patients 58.0% were categorised as being at low risk for persisting 
disability, 37.0% at medium risk and 5.0% at high risk. As expected for the construct 
validity, we found a moderate to high correlation for all questions except for activity 
question 3. The reproducibility had a quadratic-weighted kappa of .58, and a specific 
agreement of 90.9% for low-risk and 66.7% for medium-risk patients. The risk ratios 
for persisting disability for medium-risk against low-risk patients were 1.5 (95% CI. 
0.9 - 2.4) and 1.5 (95% CI. 0.5 - 4.1) for pain. The sample size for high-risk patients 
was low. 
In conclusion, we regard the original SBT is modified and able to fit patients with 
neck pain in Dutch primary care. The psychometric analysis indicates sufficiently 
reliable outcomes, although the predictive validity showed statistically insignificant 
results. 
 
Chapter 5 evaluates whether current Dutch primary-care clinicians offer tailored 
treatment as usual care to patients with low-back pain or neck pain according to their 
risk stratification, based on the SBT. 
General practitioners and physiotherapists included 184 patients with non-specific 
low back pain and 100 with neck pain. Patients completed a baseline questionnaire, 
including the Dutch SBT, for either low back pain or neck pain. A follow-up 
measurement was conducted after 3 months to determine recovery using the global 
perceived effect scale, pain using the Numeric Pain Rating Scale and function using 
the Roland Disability Questionnaire or the Neck Disability Index. A questionnaire was 
sent to the general practitioners and physiotherapists to evaluate the provided 
treatment. 
In the low back pain group, 52.2% of the patients were at low risk for persisting 
disability, 38.0% were at medium risk and 9.8% were at high risk. Overall, 24.5% of 
the patients with low back pain received a low-risk treatment approach, 73.5% a 
medium-risk and 2.0% a high-risk treatment approach. The specific agreement 
between the risk profile and the received treatment for patients with low back pain 
was poor for the low-risk and high-risk patients (respectively 21.1% and 10.0%), and 
fair for medium-risk patients (51.4%). In the neck pain group, 58.0% of the patients 
were at low risk for persisting disability, 37.0% were at medium risk and 5.0% were 
at high-risk. Only 6.1% of the patients with neck pain received the low-risk treatment 
approach.  
 The specific agreement between the risk profile and received treatment for patients 
with neck pain patients was poor for low-risk and medium-risk patients (resp. 6.3% 
and 48.0%). Agreement for high-risk patients could not be calculated. Overall, the 
medium-risk treatment approach was offered the most (90.8%) and the high-risk 
approach was applied in only 3.1% of the patients.  
We concluded that the current usual Dutch primary care for patients with non-specific 
low back pain and/or neck pain does not correspond to the advised stratified-care 
approach based on the SBT as the majority of patients receive medium risk 
treatment. The majority of low-risk patients seem to be over-treated and the majority 
of high-risk patients are possibly undertreated. Although the stratified-care approach 
has not yet been validated in Dutch primary care, these results indicate that there 
may be substantial room for improvement.  
 
Chapter 6 The royal Dutch society of physiotherapists issued a clinical practice 
guideline, this guideline focuses on diagnosing and treating adult patients with neck 
pain.  
The guideline recommends that physiotherapists classify patients as: Grade I - neck 
pain and associated disorders with no signs or symptoms suggestive of major 
structural pathology and no or minor interference with activities of daily living; Grade 
II - no signs or symptoms of major structural pathology, but major interference with 
activities of daily living; Grade III - no signs or symptoms of major structural 
pathology, but presence of neurologic signs such as decreased deep tendon 
reflexes, weakness, or sensory deficits or Grade IV - signs or symptoms of major 
structural pathology. Major structural pathologies include (but are not limited to) 
fracture, vertebral dislocation, injury to the spinal cord, infection, neoplasm, or 
systemic disease including the inflammatory arthropathies. 
In the diagnostic process neck pain grade IV may be excluded using ‘Red flags’ as a 
mean to suspect serious pathological conditions. Neck pain grade III may be ruled in 
using the Spurlings test and/or traction-distraction test or ruled-out by means of the 
Upper Limb Tension Test. Neck pain grade I and II are combined as the treatment 
does not differ between these grades. Next the course of the neck pain will be 
determined as in case of normal recovery there is no clear indication for 
physiotherapy. For normal recovery, neck pain is expected to decrease in the first 3 
weeks, limitation in daily activity will decrease within the first 6 weeks. The next step 
is establishing the subgroup when applicable: trauma-related or work-related neck 
pain. These subgroups are known to have different prognostic factors that might 
influence their recovery. Factors that might influence a delayed recovery should be 
identified and, when modifiable, be adressed in the course of treatment. The 
Numeric Pain Rating Scale and the Patient-Specific Functional Scales are 
recommended to objectify patient’s baseline status relative to pain, function and 
disability and to monitor patients’ course througout the course of treatment.  
 For patients with grade I or II neck pain with deviant recovery physical therapists are 
recommended to primairily apply cervical mobilisation or manipulation combined with 
exercise therapy. For patients with neck pain grade III physical therapists are also 
recommended to primairily apply cervical mobilisation or manipulation combined with 
exercise therapy. The cervical collar may be considered in patients with neck pain 
grade III for pain reduction but only when used sparsely.  
Physical therapists may consider the use of cognitive behavioural treatment / graded 
activity, massage, neurodynamics or neural tissue management, pillow, (kinesio) 
tape, thermal agents, and workplace interventions for patients with neck pain grade I, 
II and III when the primarily advised treatments are ineffective or not sufficiently 
effective. The use of dry needling, low-level laser, electrotherapy and ultrasound, and 
traction for patients with neck pain grade I, II and III and cervical collar for patients 
with grade I or II neck pain are recommended against. 
 
  
 Samenvatting 
  
 SAMENVATTING 
 
Hoofdstuk 2 omschrijft de mate waarin patienten de in richtlijn geadviseerde zorg bij 
acute lage rugpijn niet opvolgen (nonadherence). Gegevens van 1643 deelnemers 
aan de PACE-trial is gebruikt voor nadere analyse. De PACE-trial is een studie naar 
de effectiviteit van paracetamol bij lage rugpijn. Patiënten ontvingen richtlijn 
geadviseerde zorg welke bestond uit: geruststelling, pijnmedicatie, het advies om in 
beweging te blijven en het vermijden van bedrust. De pijnmedicatie bestond uit tijd-
contingent paracetamol, pijn-contingent paracetamol, of placebo. Tevens kregen de 
patiënten het advies om geen andere therapie te volgen of beeldvormend onderzoek 
te laten verrichten. 
De patiënten vulden een vragenlijst in en hielden een medicatie dagboek bij. 
Nonadherence was gedefinieerd als (1) het niet gebruiken van de geadviseerde 
dosis paracetamol, of (2) het gebruik van aanvullende zorg, onderzoeken, of 
medicatie gedurende de duur van het wetenschappelijk onderzoek (4 weken) Een 
multivariabele logistische regressie analyse is uitgevoerd om te bepalen welke 
factoren geassocieerd zijn met deze nonadherence.  
In de eerste week van het onderzoek is 39.7% van de deelnemers geclassificeerd 
als nonadherent. In de totale 4 weken van het onderzoek was 70.0% nonadherent, 
57.5% gebruikte niet de hoeveelheid geadviseerde paracetamol. De factoren: een 
hogere mate van veronderstelde risico op blijvende pijn, een lagere mate van 
beperkingen in activiteiten en het niet ontvangen van een inkomens compensatie 
waren onafhankelijk geassocieerd met nonadherence met odds ratio’s van .46 tot 
1.05.  
We concluderen dat het opvolgen van de in de richtlijn geadviseerde zorg bij acute 
lage rugpijn laag is. Het merendeel van de nonadherence in de PACE-trial het 
gevolg van het niet volgen van de juiste dosering van de paracetamol. 
 
Hoofdstuk 3 beschrijft de vertaling van de Keele STarT (Subgroup Targeted 
Treatment) Back-Screening Tool (SBT) in het Nederlands. Daarnaast beschrijft het 
de betrouwbaarheid en de validiteit van de SBT in de Nederlandse eerstelijns zorg 
onder 184 patiënten met aspecifieke lage rugpijn. 
De SBT is formeel heen en terug vertaald volgens de multistep benadering. 
Huisartsen en fysiotherapeuten includeerde patiënten met aspecifieke lage rugpijn, 
de patiënten vulde vragenlijsten in op baseline, na 3 dagen en na 3 maanden 
Van de 184 patiënten had 52.2% een laag risico voor blijvende rugklachten, 38,0% 
een gemiddeld risico en 9.8% hoog risico. Voor de constructvaliditeit vonden we een 
gemiddeld tot hoge Pearson’s correlatie voor vraag 3 tot en met 9 en een lage 
correlatie voor vraag 1 en 2 met hun referentie vragenlijsten. De betrouwbaarheid 
had een kwadratisch gewogen kappa van .65 en een specifieke overeenkomst van 
82.4% voor patiënten met een laag risico, 53.3% voor patiënten met een gemiddeld 
risico en 33.3% voor patiënten met een hoog risico. 
 Wat betreft de predicatieve validiteit vonden we een relatieve risico voor gemiddeld-
risico van 1.8 (95% CI: 1.0 – 3.1) en 2.7 (95% CI: 1.4 – 4.9) voor een hoog-risico 
voor blijvende beperkingen in activiteiten in vergelijking tot een laag risico.  
Wat betreft de inhoudsvaliditeit vonden we dat er geen ‘floor and ceiling’ effecten 
aanwezig waren.  
Wij concluderen dat de SBT succesvol vertaald is in het Nederland en dat de 
psychometrische eigenschappen acceptabel zijn. We beschouwen de SBT als een 
valide en betrouwbaar instrument voor patiënten met aspecifieke lage rugpijn in de 
Nederlandse eerstelijns zorg. 
 
Hoofdstuk 4 evalueert de betrouwbaarheid en validiteit van de Nederlandse versie 
van de SBT voor patiënten met nekpijn klachten. Huisartsen en fysiotherapeuten 
includeerde 100 patiënten met nekpijn welke op baseline en bij follow-up op 3 dagen 
en 3 maanden vragenlijsten hebben ingevuld. 
Van de 100 patiënten was 58.0% gecategoriseerd als laag risico voor blijvende 
nekpijn klachten, 37.0% gemiddeld risico en 5.0% als hoog risico. Zoals verwacht 
vonden we voor de constructvaliditeit een gemiddeld tot hoge correlatie met de 
referentie vragenlijst bij alle vragen met uitzondering van vraag 3  
De reproduceerbaarheid had een kwadratisch gewogen kappa van .58, en een 
specifieke overeenstemming van 90.9% bij laag risico en 66.7% bij gemiddeld risico. 
De relatieve risico’s voor blijvende beperkingen in activiteiten voor gemiddeld risico 
ten opzichte van laag risico was 1.5 (95% CI: 0.9 - 2.4) en 1.5 (95% CI: 0.5 - 4.1) 
voor blijven pijnklachten. De sample size voor hoog risico was te klein om relatieve 
risico’s te kunnen berekenen. 
We beschouwen de gemodificeerde SBT geschikt voor patiënten met nekpijn 
klachten in de Nederlandse eerste lijn. De psychometrische eigenschappen laten 
zien dat het instrument voldoende betrouwbaar is echter de predictieve validiteit laat 
geen statistisch significante resultaten zien. 
 
Hoofdstuk 5 evalueert of de huidige in Nederland gebruikelijke eerstelijnszorg, 
gerichte zorg is in lijn met de geadviseerde risico gestratificeerde zorg volgens de 
SBT bij patiënten met lage rug of nekpijn. 
Huisartsen en fysiotherapeuten hebben 184 patiënten geïncludeerd met aspecifieke 
lage rugpijn of nekpijn. Patiënten hebben een vragenlijst ingevuld, met onder andere 
de SBT, op baseline. Een vervolg vragenlijst op 3 maanden is afgenomen om herstel 
te meten middels de GPE (Global Perceived Effect scale). Daarnaast is pijn gemeten 
met de NPRS (Numerieke Pijn schaal) en is de mate van beperking in activiteiten 
gemeten met de RDQ (Roland Disability Questionnaire) of de NDI (Neck Disability 
Index). Een vragenlijst is gestuurd naar de huisartsen en fysiotherapeuten om te 
bepalen welkte therapie er is gegeven. 
Bij de patiënten met lage rug pijn was 52.2% laag risico voor chronische klachten, 
38.0% was gemiddeld risico 9.8% had een hoog risico. Slechts 24.5% van de 
 patiënten met lage rugpijn kreeg een behandeling passend bij laag risico patiënten, 
73,5% ontving een behandeling passend bij een gemiddeld risico en 2.0% ontving 
een behandeling passend bij het hoog risico beleid. De specifieke overeenstemming 
tussen het risico profiel van de patiënt met lage rugpijn en gegeven behandeling was 
laag voor laag en hoog risico (respectievelijk 21.1% en 10.0%) en redelijk voor 
gemiddeld risico patiënten (51,4%) 
Bij patiënten met nekpijn had 58,0% een laag risico voor blijvende nekklachten, 
37.0% een gemiddeld risico en 5.0% een hoog risico. Slechts 6.1% van de patiënten 
ontving een behandeling passend bij het laag risico beleid, 3.1% ontving een 
behandeling passend bij het hoog risico beleid. De meeste patienten (90.8%) 
ontvingen een behandeling passend bij het gemiddeld risico beleid. De specifieke 
overeenstemming tussen het risico profiel van de patiënt met nekpijn en de gegeven 
behandeling was laag voor laag en hoog risico (respectievelijk 6.3% en 48.0%) en 
niet te bepalen voor hoog risico door een te kleine populatie.  
We concluderen dat de huidige, in Nederland gebruikte, eerstelijnszorg voor 
patiënten met lage rugpijn of nekpijn niet overeenkomt met het gestratificeerde 
beleid volgens de SBT. De meerderheid van de patiënten ontvangt een behandeling 
passend bij een gemiddeld risico op aanhoudende klachten. De meerderheid van de 
laag risico patiënten lijkt derhalve over-behandeld en de meerderheid van de hoog 
risico patiënten lijkt onder-behandeld te worden. Ondanks dat de risicostratificatie 
met passend behandelbeleid nog niet is gevalideerd in de Nederlandse eerste lijns 
zorg, impliceren deze resultaten dat er ruimte is voor verbetering. 
 
Hoofdstuk 6 Het Koninklijk Nederlands Genootschap voor Fysiotherapie heeft een 
richtlijn uitgegeven welke zich focust op de diagnose en behandeling van patiënten 
met nekpijn. 
De richtlijn adviseert fysiotherapeuten om patiënten te classificeren in een van de 
volgende gradaties. Graad I: Nekpijn zonder tekenen of symptomen die kunnen 
wijzen op grote structurele pathologie en die niet of nauwelijks invloed heeft op 
activiteiten in het dagelijks leven. Graad II: Nekpijn zonder tekenen of symptomen 
die kunnen wijzen op grote structurele pathologie, maar die wel een forse invloed 
heeft op activiteiten in het dagelijks leven. Graad III: Nekpijn zonder tekenen of 
symptomen die kunnen wijzen op grote structurele pathologie, waarbij wel 
neurologische symptomen aanwezig zijn, zoals verminderde peesreflexen, 
spierzwakte of sensibiliteitsstoornissen (hypo- of hyperesthesie) in de bovenste 
extremiteit, bijvoorbeeld als gevolg van een cervicale hernia of stenose. Graad IV: 
Nekpijn met tekenen of symptomen die kunnen wijzen op ernstige structurele 
pathologie. Ernstige structurele pathologie omvat (maar is niet beperkt tot): fracturen, 
vertebrale dislocaties, schade aan het ruggenmerg, infecties, tumoren of 
systemische ziekten, waaronder gewrichtsontstekingen. 
In het diagnostisch proces wordt nekpijn graad IV uitgesloten door middel van ‘Rode 
vlaggen’ welke kunnen wijzen op ernstige pathologie. Nekpijn graad III kan bepaald 
 worden met behulp van de Spurlings test en/of de traction-distraction test of 
uitgesloten worden met behulp van de Upper Limb Tension Test. Nekpijn graad I en 
II zijn in de richtlijn gecombineerd omdat de behandeling niet verschillend is tussen 
deze twee gradaties. De volgende stap in het proces is het bepalen van het beloop 
van de nekpijn, omdat er bij een normaal beloop geen duidelijke indicatie is voor 
fysiotherapie. Bij een normaal beloop verwachten we een afname van pijn in de 
eerste drie weken en een afname van beperking in activiteiten in de eerste 6 weken. 
De derde stap is het bepalen welke subgroep van toepassing is; werk-gerelateerde 
nekpijn of trauma-gerelateerde nekpijn. Deze subgroepen kennen andere 
prognostische factoren welke een negatieve invloed hebben op het herstel. Deze 
factoren dienen geïdentificeerd te worden en, wanneer beïnvloedbaar, dienen ze 
geadresseerd te worden in de behandeling. De NPRS (numerieke pijnschaal) en 
PSK (Patient Specifieke Klacht) worden geadviseerd om objectief op baseline de 
status van de patiënt in kaart te brengen met betrekking tot pijn, functie en 
participatie. Tevens kunnen deze metingen gebruikt worden om het beloop van het 
beloop te bepalen gedurende de therapie. 
Bij patiënten met graad I of II nekpijn en een afwijkend beloop worden de 
fysiotherapeuten geadviseerd om primair cervicale mobilisaties of manipulaties uit te 
voeren in combinatie met oefentherapie. Bij patiënten met nekpijn graad III worden 
fysiotherapeuten geadviseerd om primair cervicale mobilisaties of manipulaties uit te 
voeren in combinatie met oefentherapie. Eventueel kan een halskraag worden 
overwogen bij patiënten met nekpijn graad III voor pijnreductie maar enkel voor 
kortdurend gebruik. 
Fysiotherapeuten kunnen gebruik maken van; cognitieve gedragstherapie, graded 
activity, massage, neurodynamica, advies voor een ergonomisch kussen, (kinesio) 
tape, warmte of koude therapie, of werkplek interventies bij patiënten met nekpijn 
graad I, II of III. Deze interventies kunnen worden toegepast wanneer de primaire 
interventie onvoldoende of geen effect heeft gehad. Het gebruik van dry needling, 
low-level laser, elektrotherapie en ultrageluid (en/of shockwave), en tractie bij 
patiënten met nekpijn graad I, II en II en een halskraag bij nekpijn graad I en II 
worden afgeraden. 
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